Strategy and Policy

by Erin E. Bonar, Ph.D et al. – News Release Michigan Medicine – University of Michigan

Among people over 50 who use cannabis, those most likely to drive after partaking are men, people who use daily, and those who use THC-containing products for mental health reasons

With cannabis-related vehicle crashes on the rise, a new study suggests that prevention campaigns shouldn’t focus just on young people.

In fact, 20% of people over 50 who use cannabis products reported that at least once in the past year, they had driven within two hours of using the drug.

That means they likely got on the road while the THC in cannabis still impaired their reaction times, attention and other abilities that are important to driving safely.

The findings, from a University of Michigan team led by addiction psychologist Erin E. Bonar, Ph.D., are published in the journal Drug and Alcohol Dependence. The data behind the study come from the National Poll on Healthy Aging, based at the U-M Institute for Healthcare Policy and Innovation.

Bonar and the poll team published an initial analysis in late 2024, but the new paper dives deeper into the data.

“So much of the effort to reduce ‘driving while high’ through awareness campaigns has focused on young people, but our findings show this is a cross-generational issue,” said Bonar, a professor of psychiatry at the U-M Medical School. “Targeting messages at those middle age and older adults with the highest risk of post-use driving could also include message about the options for addressing the health issues that they may be trying to self-treat with cannabis.”

Those most likely to drive after using cannabis

Adults age 50 and over who use cannabis products daily or nearly daily were three times as likely to say they had driven soon after using, compared with those who only use cannabis rarely, the study finds.

Those who use cannabis for mental health reasons were twice as likely to say they’d driven after using it, compared with those who didn’t list mental health among their reasons for choosing to use cannabis.

And men over 50 who use cannabis were 72% more likely to drive after using THC-containing products, compared with women in the same age group who use cannabis.

In all, the poll showed that 21% of people age 50 and up had used a cannabis product at least once in the last year, including 27% of those aged 50 to 64 and 17% of those aged 65 and up.

Of the 729 respondents over 50 who said they had used cannabis in the past year, 27% said they use it daily or almost daily, while 43% had used it only once or twice. The rest were divided between those who use monthly (14%) and weekly (16%).

Beyond the riskiest groups

While the study results suggest some groups of people over 50 who could especially benefit from targeted preventive messaging about the risks of driving after using cannabis, broad-based messaging appears to be needed, Bonar says.

In all, 65% of the people in the survey who said they use cannabis were between the ages of 50 and 64, with the rest over 65. But there was no difference between the age groups in likelihood of post-cannabis-use driving.

There were also no differences in post-use driving by age, race, ethnicity, income, history of loneliness, or caregiver status.

Those who live in states where recreational cannabis has been legalized were no more likely to drive after using the drug than those living in other states.

In addition to mental health, the poll asked about other reasons that adults over 50 might use cannabis, including several related to health. In all, 52% of people over 50 who use cannabis cited a mental health or mood-related motive for using cannabis, and 67% cited a sleep-related motive.

There was no difference in whether participants drove after cannabis use based on using it for pain, other medical reasons or sleep-related reasons, once the researchers adjusted the data. However, there was some signal that those who use it for sleep reasons may be more likely to drive after using.

This suggests a need to help adults age 50 and up understand that there are options for treating these conditions that have much more evidence behind them than cannabis, said Bonar. It also highlights the need for more robust research on which health conditions cannabis might address most effectively.

Age-specific messaging

Bonar and her co-authors also note that driving guidelines for people over age 50 who choose to use cannabis should also consider the effects of aging on cognitive and motor abilities, and the potential for interactions between cannabis and the prescription drugs that these adults are more likely to take.  

Helping adults over 50 who choose to use cannabis understand the potential impacts of today’s more potent cannabis, compared with the forms available in their younger years, is also important, says Bonar.

And when advising people over 50 about reducing driving risks related to their cannabis use, she said, health care providers and public health agencies may want to focus on strategies like using cannabis at times when they’re unlikely to need to drive, such as before bedtime, and the importance of planning ahead for safe transportation via a designated driver or ride share service.

Bonar is a member of IHPI and of the U-M Addiction Center, the U-M Injury Prevention Center and the U-M Eisenberg Family Depression Center.

In addition to the new paper on cannabis use and driving among people over 50, the National Poll on Healthy Aging recently issued a report on driving behaviors among people age 65 and over. Find it at https://michmed.org/w4Ayn

Bonar and colleagues also recently published an Injury Prevention Center report on the impact of recreational cannabis legalization in Michigan, including data on motor vehicle crashes and fatalities linked to cannabis.

In addition to Bonar, the study’s authors are Lianlian Lei, Matthias Kirch, Kristen P. Hassett, Erica Solway, Dianne C. Singer, Sydney N. Strunk, J. Scott Roberts, Preeti N. Malani, and NPHA director Jeffrey T. Kullgren.

Citation: Driving after cannabis consumption among US adults ages 50 years and older: A short communication, Drug and Alcohol Dependence, DOI:10.1016/j.drugalcdep.2025.112985, https://authors.elsevier.com/a/1mCG51LiD3LPLZ

Source: https://www.eurekalert.org/news-releases/1109142

News Article by US News ReporterDec 01, 2025

There is “insufficient” evidence supporting the use of cannabis or cannabinoids for most medical purposes, a new review has concluded.

“We reviewed the totality of the evidence—over a thousand studies with emphasis on randomized trials, meta-analyses, and systematic reviews,” Dr Kevin Hill, one of the review authors, and director of addiction psychiatry at Beth Israel Deaconess Medical Center, and a professor of psychiatry at Harvard University, told Newsweek.

He said that “beyond the FDA-approved indications, the evidence for cannabis and cannabinoids as a medical treatment is limited.”

The review was published online in the peer-reviewed medical journal JAMA Network on November 26.

Why It Matters

There has been increasing use of cannabis and cannabinoids for medical treatment in recent years. It has gained popularity among cancer patients, for managing nausea, pain and reduced appetite, and it is favored among patients with chronic pain for its analgesic properties.

However, its use medically has gathered some concern, as while certain patients may experience benefits, some medical professionals have said that there is not enough research to determine if the positives outweigh any future negatives.

After the Senate passed its funding package to end the U.S. government shutdown, which included a measure that will lead to the banning of many THC products, the issue of cannabis use has been in the spotlight.

What The Review Found

The review found that 27 percent of adults from the U.S. and Canada have used cannabis for medical purposes, while 10.5 percent of Americans report using cannabidiol (CBD) for therapeutic purposes.

“Cannabis and cannabinoids like CBD have a broad range of effects, so, with so many people suffering from medical problems, it is not hard to see why they might consider cannabis and cannabinoids as treatments,” Hill said.

However, he said that “the evidence is not strong” for their use medically.

While doctors may “consider cannabis and cannabinoids as third-line treatments in various clinical scenarios,” Hill said, “the lack of evidence coupled with significant risks means that, most often, the risks outweigh the benefits.”

The review found that almost a third of adult users of medical cannabis go on to develop a cannabis use disorder—a complex condition that is a type of substance use disorder, where a patient can experience a problematic pattern of cannabis use that causes them distress or impairs their life.

It also found that daily inhaled cannabis use compared to nondaily use was associated with higher risks of coronary heart disease, heart attack, and stroke,

“The adverse effects of cannabis upon one’s physical health are becoming more well-defined,” Hill said.

He said that the purpose of this review was to provide clinicians and patients with “better information with which to have sensible, evidence-based conversations,” conversations about medical treatment which he said should take place between doctors and patients, and “not between budtenders and customers in dispensaries.”

What Other Experts Think

Jonathan Caulkins, a professor of operations research and public policy at Carnegie Mellon University, who was not involved in the review, told Newsweek that while there is “high-quality evidence supporting certain very specific medical uses,” most medical use is “predicated on much less evidentiary basis, and below what is expected for FDA approval.”

He said that what is “important” about this review is that it helps “counter the messaging from cannabis treatment advocates, who promote the good news, and the hopes, without balance or caution.”

“The actual situation is nuanced, and more gets written that pushes for an overly optimistic view of cannabis’ medical value,” he said.

Yasmin Hurd, chair of translational neuroscience and the director of the Addiction Institute at Mount Sinai, also told Newsweek that the findings are “notable” because it “confirms what has been previously published from other reviews and consensus reports like those from the National Academies, noting that there is insufficient evidence for the use of cannabis to treat most medical conditions.”

While the authors have “done a very comprehensive and in my view very useful review of this topic,” Dr Igor Grant, a professor of psychiatry and director of the HIV Neurobehavioral Research Program and Center for Medicinal Cannabis Research, at the University of California, San Diego, told Newsweek, “it is clear from the way the article is written that the authors have significant concerns about the use of medicinal cannabis, and as such have tended to emphasize many of the negatives, including potential side effects.”

He said that this “does not mean that the side effects are not there, nor does it negate the fact that evidence for efficacy of medicinal cannabis is weak in many areas. But there does seem to be a definite slant.”

He also said that while this review highlights cardiovascular risks, other research has also shown there is “actually no statistically reliable evidence to suggest that cannabis users suffer more cardiovascular risk, including no effect on hypertension, myocardial infarction, and presence of coronary atherosclerosis.”

What People Are Saying

Caulkins told Newsweek: “We customarily expect medicinal drugs to be produced in a way that guarantees consistency from dose to dose. Every pill in a bottle of pills that is prescribed by a physician, manufactured by a pharmaceutical company and distributed by a licensed pharmacy should have essentially the exact same dose. With the exception of the FDA-approved and regulated cannabinoids (which account for a tiny share of all consumption that is described or understood to be “medical cannabis”), there is not that same quality control for medical cannabis.”

He added: “Cannabis smoke contains known carcinogens. Sometimes good medical practice exposes patients to carcinogenic risk, notably radiation treatment does. But we do that carefully and knowingly, because the risk of untreated cancer is greater than the risk that radiation therapy will create new cancer. But given that in many cases the upside benefit of medical cannabis is not well established, it is striking how cavalier the system is with respect to known carcinogens present in cannabis smoke. For most categories of consumer products, the presence of known carcinogens is sufficient to have that product taken off the shelves, even if there are not epidemiological studies documenting effects on cancer rates at the population level. For whatever reason or reasons, we collectively seem surprisingly unconcerned about that risk regarding smoked cannabis, medical or non-medical.”

Hurd told Newsweek: “There remain numerous concerns about cannabis for medical use since there is so little known about whether it works, what particular conditions it might be helpful to treat and what dose and dosing regime for clinicians to recommend. In addition, there are also concerns that individuals will use ‘medicinal cannabis’ obtained from sources where the contents are not verified and cannabis with high THC concentration has well known significant side effects. Cannabis should be used with caution in medical settings. As such, like many medicines, especially where there is very limited information available, it is best to start low dose and go slow. Also, cannabis should not be the first line therapy and instead used only for conditions where conventional therapies have failed.”

She added: “It is important that the public also begins to better understand that cannabis is a very complex plant with hundreds of chemicals whereas ‘medicine’ is normally a product that has specific, well studied components. Also, cannabis is different from specific cannabinoids, like cannabidiol (CBD), which has FDA approval for the treatment of certain epilepsy conditions.”

Grant told Newsweek: “While I agree that physicians who are counseling patients about potential use of cannabis for various indications need to both warn patients about lack of evidence in many cases, the possibility of side effects, and certainly evaluate a patient in the event they have major psychiatric or substance use disorder, there are, as they note protocols for doing this, and in some ways, assuring safety. I believe also that the risk of people who use medicinal cannabis, who are often people who are older with various kinds of chronic conditions, is rather low that they will systematically increase their use to the point of developing a cannabis use disorder. Cannabis use disorder is real, and a concern, but very unlikely to be a problem in the clinical setting. The article tends at times to conflate recreational and medicinal use: that’s a bit like using data from opioid addiction to comment on appropriate use of opioids in a clinical setting.”

Source: https://www.newsweek.com/does-cannabis-actually-have-medical-benefits-11118810

December 03, 2025

|

Houston –The U.S. Drug Enforcement Administration is intensifying its fight against the deadly threat of synthetic opioids with the launch of Fentanyl Free America, a comprehensive enforcement initiative and public awareness campaign aimed at reducing both the supply and demand for fentanyl. This effort underscores DEA’s unwavering commitment to protecting American lives and communities from the devastating impacts of fentanyl, which claimed nearly 50,000 lives last year according to the Centers for Disease Control and Prevention (CDC). 

Through intensified enforcement operations and heightened intelligence, DEA is applying unprecedented pressure on the global fentanyl supply chain, forcing narco-terrorists, like the Sinaloa Cartel and CJNG Cartel, to change their business practices. This has led to encouraging signs of progress. DEA laboratory testing indicates 29% of fentanyl pills analyzed during fiscal year (FY) 2025 contained a potentially lethal dose, a significant drop from 76% of pills tested just two years prior in FY 2023. Additionally, fentanyl powder purity decreased to 10.3%, down from 19.5% during the same time period. These reductions in potency and purity correlate with a decline in synthetic opioid deaths to levels not seen since April 2020. 

As of December 1, 2025, DEA has seized more than 45 million fentanyl pills, and more than 9,320 pounds of fentanyl powder, removing an estimated 347 million potentially deadly doses of fentanyl from our communities. DEA intelligence indicates a shift in cartel operations, with increased trafficking of fentanyl powder and domestic production of fentanyl pills. The seizure of more than two dozen pill press machines in October further highlights this trend.

The DEA Houston Field Division was one of 23 domestic field divisions and seven foreign divisions that initiated Operation Fentanyl Free America in October. During a period of a month, this targeted enforcement effort resulted in the seizure of:

  • 350 Counterfeit pills 

    • which is equivalent to 103 deadly doses 

  • 149 pounds fentanyl powder

  • 3154 pounds methamphetamine

  • 30 pounds of cocaine

  • 36 firearms

  • $249,285 U.S. currency

“Operation Fentanyl Free America seizures in October highlighted the ongoing threat of fentanyl. Despite the steady decline in overdoses in most of the South Texas,” said Special Agent in Charge of the Houston Field Division Jonathan C. Pullen. Fentanyl is still an imminent threat, and we can’t afford to look the other way. We will continue to get this poison off the streets, ensuring safer communities for generations to come” 

The threat of poly-drug organizations; cartels that traffic a portfolio of drugs opposed to a single substance became even more apparent during Operation Fentanyl Free America.  Aside from producing less potent fentanyl, the cartels have increasingly diversified their operations in an attempt to minimize their risks and maximize profits, an evolution driven by opportunity and greed.

DEA remains at the forefront of the fight to disrupt trafficking networks and strengthen the government’s response to this epidemic.  Fentanyl Free America represents DEA’s heightened focus on enforcement, education, public awareness, and strategic partnerships. The goal of the campaign is clear: eliminate the fentanyl supply fueling the nation’s deadliest drug crisis. Since 2021, synthetic opioids have claimed nearly 325,000 American lives. 

The Fentanyl Free America campaign also emphasizes the importance of public engagement.  DEA encourages everyone from community leaders, clergy, educators, parents, physicians, pharmacists, and law enforcement to take an active role in raising awareness by protecting others through education; preventing fentanyl poisonings by understanding the dangers; and supporting those impacted.  Free resources including posters, radio advertising, billboards, and social media resources are available at dea.gov/fentanylfree.  

DEA’s efforts are part of a larger whole-of-government strategy to dismantle transnational criminal organizations and protect U.S. communities from fentanyl.  

SOURCE: https://www.dea.gov/press-releases/2025/12/03/dea-launches-fentanyl-free-america-initiative-combat-synthetic-drug-3

HRH has good intentions, but her view is dehumanising and damaging

The Princess of Wales has called for an end to the ‘stigma’ of addiction 
Credit:Paul Grover/Daily Telegraph/PA Wire/PA Images

The Princess of Wales is patron of The Forward Trust, a charity devoted to assisting addicts to remain abstinent from their drug of addiction. She has just spoken out forcefully against the view that addiction is weakness of will or any kind of moral problem.

“Addiction is not a choice or a personal failing,” she said, implying thereby that it was a medical condition like any other, such as Parkinson’s disease or multiple sclerosis. She said that “people’s experience of addiction in still shaped by fear, shame and judgment, and that this ought to change”.

I am sure that HRH meant well, and that she feels genuine sympathy for addicts; but unfortunately, her view is simple, unsophisticated, dehumanising and empirically false.

It is dehumanising because, by denying that addiction is a choice, it deprives addicts of their agency both in theory and to a certain extent in practice. If, after all, you persuade someone that he does not make a choice in doing something, you also persuade him that choice cannot prevent him from doing it. He is not a human being like you and me, but a helpless feather on the wind of circumstance.

This turns him into an object, not a subject, both to himself and others. Such a view is implicitly degrading, demeaning and far from compassionate. It implies the need for an apparatus of care to look after him, much as one would look after an animal in a menagerie, with kindness but not with much respect.

Take the case of the injecting heroin addict and think what he has to do and learn to become such an addict. He has to learn where to obtain heroin and how to prepare it. He has to learn to disregard its unpleasant side effects. He has to overcome a natural aversion to pushing a needle into himself. This is not something that just happens to him.

Moreover, not only do most addicts take the drug for some time before becoming physically addicted to it, but they are fully aware in advance of the consequences of taking the drug long-term. Addicts are not “hooked” by heroin, as they often put it; rather, they hook heroin.

It is untrue that addicts require a professional apparatus to overcome their addiction. Millions of people have given up smoking, though nicotine is addictive. During the Vietnam War, thousands of American soldiers addicted themselves to heroin and gave up, with almost no assistance, one they returned home.

In 1980, Porter and Jick pointed out that people treated with strong painkillers as in-patients in hospital did not go on to become addicts once they left hospital. This was unfortunately interpreted to mean that such drugs were not addictive; but, on the contrary, it shows that addiction, in the sense of continuing addictive behaviour, is not straightforwardly a physiological condition.

At the root of the Princess’s misapprehension is the post-religious or secular view that if a person is the author of his own downfall, he is due no sympathy or compassion. It is a highly puritanical view, and since we do not want to be puritans, we make the problem a medical one instead. But since we are all sinners and the authors of our own downfall, at least in some respect or other, this also has the corollary that sympathy or compassion is due to no one when he needs it.

The Princess appears to think that if you say to an addict that he has behaved, and continues to behave, foolishly and badly, you are necessarily saying to him, “Go away, darken my doors no more”. She seems to think that the truth, far from setting people free, will imprison them until someone comes along with a technical key to unlock them.

Of course, some addicts benefit from assistance, but not for the reasons the Princess supposes. Medication may reduce their physical sufferings, and if we take once more the example of injecting heroin addicts, we discover that they may well have so destroyed their relations with everyone – their families and friends – that there is no one to whom to turn if they desire to change their ways. They thus need a helping hand, but this is not the same as removing fear or stigma (a very necessary, though not sufficient, aid to civilised life). Though she did not mean them to be so, the Princess’s words were not so much demoralising, as amoralising.

Source: https://www.telegraph.co.uk/gift/51db8fdbd5d80cb6

Filed under: Strategy and Policy,UK :

  • Emerging drugs, which include designer drugs and new psychoactive substances, are substances that have appeared or become more popular in the drug market in recent years.
  • Emerging drugs have unpredictable health effects. They may be as powerful or more powerful than existing drugs, and may be fatal.
  • Because drug markets change quickly, NIDA supports the National Drug Early Warning System (NDEWS), which tracks emerging substances. NIDA also advances the science on emerging drugs by supporting research on their use and on their health effects.

Source: https://nida.nih.gov/research-topics/emerging-drug-trends

 

The European Union Drugs Agency (EUDA) today launched the new EUDA Health and Security Threat Assessment System (ETAS), designed to strengthen Europe’s preparedness for serious and emerging drug-related threats and to support coordinated responses. Foreseen under the EUDA regulation, the service was unveiled at the meeting of the Heads of Reitox national focal points (NFPs), taking place this week in Lisbon, bringing together representatives from across Europe.

ETAS will help EU Member States identify, assess and respond to drug-related health and security threats linked to drug markets, illicit substances and changing patterns of use. The system provides structured, evidence-based assessments to support timely decisions on mitigation, early preparedness and strategic responses at national and EU level.

As a core component of the EUDA’s wider preparedness framework, ETAS operates in close coordination with the European Drug Alert System (EDAS), the EU Early Warning System on new psychoactive substances and the Network of forensic and toxicological laboratories. Together, these services combine early warning, rapid alerts and in-depth assessments, reinforcing Europe’s capacity to detect and respond to fast-evolving drug-related risks.

Threat assessments can be triggered by requests from an EU Member State or the European Commission or when signals from the EUDA’s monitoring, alert and early warning systems indicate that a coordinated response may be needed. Member State requests are submitted via the EUDA Management Board member or through the national focal point. The NFPs act as key contact points for ETAS and contribute throughout the assessment process.

Drawing on data from health, law enforcement and laboratory sources, as well as expert input from national authorities, ETAS delivers practical options for action, tailored to different threats.

The first assessments under the new system are focusing on highly potent synthetic opioids and the availability and harms of crack cocaine in the EU. These are being carried out in close cooperation with the countries concerned. A pilot threat assessment, published in June 2025, examined the evolving presence and impact of highly potent synthetic opioids (particularly ‘nitazenes’ and carfentanil) in the Baltic States.

These early cases illustrate how the new system will support Member States and EU institutions in turning evidence into concrete measures on the ground, contributing to a safer and more resilient Europe.

EUDA and national focal points discuss new partnership framework

A central issue at this week’s meeting is the ‘Reitox Alliance’, a new partnership framework between the EUDA and the NFPs. Building on decades of shared experience, the alliance aims to strengthen cooperation, enhance preparedness and ensure a coordinated European response to emerging drug-related challenges.

The new operating framework, set for adoption by the Management Board next month, will replace the previous Reitox operating framework, functioning since 2003. The alliance aligns the network’s activities with the EUDA’s updated mandate and promotes mutual support, capacity building and innovation among Member States.

The meeting will also focus on policy and institutional updates, scientific projects, national reporting, communication activities and planning for 2026. Topics include cannabis policy, prisons and international cooperation.

This is the last Reitox meeting under the current Executive Director, Alexis Goosdeel whose mandate ends on 31 December this year. Speaking at the event, Mr Goosdeel said: ‘The new Reitox Alliance will mark a significant step forward in how we work together as a European network, and will give us a stronger, more coordinated platform for tackling the complex drug challenges we face. ETAS is just one example of how this renewed partnership can translate shared expertise into concrete, operational services that help Member States anticipate threats and act quickly. As I conclude my mandate, I am proud of what we have achieved together and confident that this enhanced cooperation will support Europe’s preparedness for years to come.’

Source: https://www.euda.europa.eu/news/2025/new-threat-assessment-system-launched-strengthen-eu-response-drug-related-threats_en

 

exp-customer-logo  TAMPA BAY TIMES
OPINION PIECE :

Patrik Ward is an economics student and member of the Adam Smith Society at the University of Tampa.

Abigail R. Hall is a senior fellow at the Independent Institute in Oakland, Calif., and an associate professor of economics at the University of Tampa.

What looks like an anti-drug measure may, in practice, be a show of power.
The recent U.S. strikes on alleged Venezuelan drug-traffickers in the Caribbean were framed as a necessary measure against transnational crime. Beyond their questionable legality, these measures risk deepening the very markets they seek to destroy. In attempting to sink traffickers at sea, the U.S. may have buoyed the economics of the drug trade.

In late October, U.S. naval forces carried out multiple strikes against vessels in the Caribbean suspected of transporting drugs linked to Venezuelan criminal networks. According to U.S. officials, the strikes sought to disrupt smuggling routes and weaken cartels. Venezuelan officials condemned the attacks as a violation of sovereignty.

Although U.S. leaders defended them as part of a broader campaign against narcotics trafficking, the timing and targets suggest a broader strategic move. Venezuela’s government remains deeply corrupt and internationally isolated, making it an easy symbol for demonstrating U.S. strength in the region. What looks like an anti-drug measure may, in practice, be a show of power—a bid to assert influence and signal strength, rather than a coordinated effort to reduce trafficking.

On a baseline level, a tougher stance on trafficking sounds like a beneficial policy. If the United States government raises the “punishment” for trafficking (i.e., killing traffickers on the open sea), smugglers may reconsider their choice.

However, illicit markets don’t mirror textbook logic. They adapt. By raising the risks, these strikes may have also raised the rewards, inflating prices, shifting routes and enriching the most dangerous agents.

This dynamic, common in financial markets, is often referred to as the “risk premium” — higher expected punishment leads traffickers to demand higher prices to compensate for the danger.

In the short run, some suppliers in the drug trade may exit the market. But those who stay are those most willing to take extreme risks or who already have the means to absorb them. In this case, cartels with deep pockets and little concern for collateral damage. Enforcement ends up selecting the most violent, not the most vulnerable.

As enforcement intensifies in one region, illegal activity doesn’t disappear — it relocates. This “balloon effect” means that squeezing the supposed drug trade in Venezuelan waters may simply push it toward alternative routes through Central America, the Caribbean or the West Coast. This doesn’t reduce the flow of drugs, but the geography of violence and corruption shifts, destabilizing communities far from the original target.

The economic effects don’t end there. As risk and costs climb, drug producers face incentives to cut corners and stretch profits by diluting drug purity. This generally takes the form of mixing cheaper — and often deadlier — additives like fentanyl. What begins as a “security measure abroad” can quickly spiral into a public-health crisis at home as domestic demand persists, and drug supply grows more potent and unpredictable.

These mechanisms reveal that when policy targets symptoms rather than the underlying causes or incentives, markets evolve faster than enforcement can adapt. The United States has spent decades trying to outgun an industry whose demand base is resilient and concentrated domestically. The real question isn’t whether to combat trafficking — it’s how. Every dollar spent on maritime strikes is a dollar not spent on reducing domestic demand, expanding treatment capacity or fostering economic alternatives in producer countries.

So, what can we do differently?

If the goal is to weaken trafficking networks, policymakers would do better to strike the cartels economically, not their boats. Forty years of interdictions — from the Caribbean to Plan Colombia — show that cutting supply routes rarely cuts supply. Research suggests that every dollar spent on treatment and prevention reduces drug consumption up to five times more than enforcement and interdiction spending.

Real deterrence starts at home. Expanding access to treatment, addressing poverty and mental health crises and targeting the financial pipelines that launder cartel profits strike demand and incentives directly. Cooperation with Latin American governments can then make enforcement smarter, not louder. The point isn’t to dominate the Caribbean — it’s to make drug trafficking a losing business model.

A purely militarized approach treats illicit markets as a law enforcement problem when it’s fundamentally an economic one. The logic of the market doesn’t vanish at sea — it simply resurfaces somewhere else.

Source: https://www.tampabay.com

301 deaths. 301 names, ages, faces removed. 301 families, communities, homes (or home equivalents) emptied. 

In 2023, there were 301 opioid-related overdose deaths in Alameda County. Standing alone, that figure isn’t alarming to those of us reading behind “safe” walls on our expensive devices. 

Nothing exposes us to the truth more than cold numbers. This data-driven meta-analysis will show there is far more to concern about the complexities that eventually result in the plague of opioids claiming those 301, and thousands more, lives.

The acceleration of the Alameda County crisis

Those 301 Alameda County lives claimed by opioids in 2023 represent a 60% increase  from 2022. Alameda County experienced the worst increase of all Bay Area counties in opioid overdose deaths from 2018-2021; Alameda’s rates tripled over this time while neighboring (Courtesy Alameda County)

There is an apparent inequity within the county. African-Americans’ fatal overdose rates are triple  that of the county average, and the homeless comprise 30% of all overdose deaths. 

(Courtesy Alameda County)

The teen paradox: Less use, more deaths

The focus is on teens, right? That would make sense. After all, teen substance use excluding cannabis is DOWN, compared to the 20.9% of high school juniors in 2002, the 8% figure of 2022 represents major improvement. 

Despite this, death rates are not improving. In fact, teen overdose deaths doubled in the eight short months between August 2019 and March 2020. As of 2022, 22 teens were dying WEEKLY from drug overdose in the United States. And overdoses are now the third leading cause of death for the youth, after guns and cars.

Fentanyl changed it all.

Now, over 75% of teen overdose victims’ lives are claimed by fentanyl. There was nearly a 300% INCREASE in fentanyl deaths aged 15-19 from 2018 to 2021. 

The problem isn’t necessarily addiction. It’s contamination. 

84% of teen overdose deaths are unintentional, and around a quarter of teen overdose deaths involve fake prescriptions. Fatal drugs like fentanyl spread through adult markets due to their potency and make their way to teens by accident. Most teens do not even get hooked onto the drugs that kill them.

Treatment inequality and solutions

Teen treatment right now is almost a scandal. While 42% of adults aged 45+ receive medications for opioid use disorder within three months of diagnosis, only 5% of teens do. Out of every five teens with substance use disorder, only one gets treatment.

Regardless of everything, prevention programs are still a solution. Project Towards No Drug Abuse (Project TND) has shown a 25% reduction in hard drug use. Medication-Assisted Treatment (MAT) reduces overdose deaths by 70-80%. Endless life-saving rescues by naloxone have been documented by near-death survivors. 

It is not that there are no solutions. Ironically, teens are the ones with the least access to drugs. We know what works, and Alameda County cares for its people. The change to prevent teen opioid overdose deaths must originate in expanding access and awareness to the systems proven to save lives.

Source: https://www.pleasantonweekly.com/alameda-county/2025/11/17/the-data-driven-paradox-of-prevention/


This article was written as part of a program to educate youth and others about Alameda County’s opioid crisis, prevention and treatment options. The program is funded by the Alameda County Behavioral Health Department and the grant is administered by Three Valleys Community Foundation.

The Government’s new mandate to carry out random oral-fluid roadside drug testing marks a milestone in New Zealand’s road safety policy

Under recently passed laws, police can now stop any driver, at any time, to screen with an oral swab for four illicit substances: THC (cannabis), cocaine, methamphetamine and MDMA (ecstasy).

Police will begin the rollout in Wellington in December, with nationwide coverage expected by mid next year.

Drivers will face an initial roadside swab taking a few minutes; a positive result triggers a second test. If confirmed, the driver will face an immediate 12-hour driving ban and have their initial sample sent to a lab for evidential testing.

With nearly a third of all road deaths involving an impairing drug, moves like this are clearly aimed at a serious problem.

Efforts by the previous Labour-led government stalled because no commercially available oral-fluid device met the evidentiary standards required at the roadside.

The government now appears to have what it needs to begin roadside testing. But it remains unclear whether this policy will achieve its goal of preventing truly impaired driving.

The science behind cannabis and driving

The research on cannabis and driving impairment is mixed. Many studies show an associative rather than causal link: people who use cannabis more often tend to report more crashes, but not whether those crashes happened while they were impaired.

Unlike alcohol – where blood-alcohol concentration closely tracks impairment – no such relationship exists for THC. Cannabis is fat-soluble, so traces linger in the body and appear in saliva long after any intoxicating effect has passed, making saliva testing a relatively poor proxy for impairment.

For the other targeted drugs – the stimulants methamphetamine, cocaine and MDMA – the connection to driving impairment is also unclear. At lower doses, stimulants can even improve certain motor skills. The risks are instead tied to perceptual shifts or lapses in attention, which a saliva test cannot detect.

Because cocaine and meth remain illegal globally, it is difficult to conduct the controlled studies needed to link presence and impairment.

The policy’s focus on just four illicit drugs also raises questions of scope. In practice, these are among the easiest and most visible substances to target: the low-hanging fruit.

Yet impairment from prescription medications such as sedatives or painkillers is far more common and remains largely self-policed.

Responsibility falls to individuals and their doctors to decide when it is safe to drive – a much bigger problem than many realise.

Police expect to conduct about 50,000 tests a year – around 136 a day nationwide – compared with more than four million alcohol breath tests annually.

While that’s a modest number, the introduction of roadside breath testing in the 1980s proved transformative. Alcohol consumption, which had been rising for decades, peaked around 1980 and then began to fall after the combined impact of breath testing and public awareness campaigns.

Whether the new drug-testing programme can produce a similar deterrent effect – without that level of visibility or education – remains to be seen.

Even if it does, the overall impact may be small. Drug use and drug-driving are far less common than alcohol use ever was, so the scope for large behavioural change is limited.

The problem of lingering traces

Another pressing question is what happens when the test detects traces of cannabis long after impairment has passed. THC can remain detectable in regular users for up to 72 hours, even though its intoxicating effects last only a few.

That means a medicinal cannabis patient who took a prescribed dose the night before – or a habitual user with high baseline levels – could therefore test positive while driving safely.

Although the law provides for a medical defence, there is still no clear procedure for proving a prescription at the roadside. Few people carry that documentation, and it’s uncertain whether digital GP records would be accepted.

In practice, some law-abiding drivers will inevitably be caught up in the process simply because of residual traces that pose no safety risk. Conversely, an inexperienced cannabis user may feel heavily impaired yet return a low reading.

This uncertainty reflects a deeper flaw in the system. When the previous government first designed the policy, it intended to test for impairment.

Because no devices could meet the evidentiary standard, the law was amended to test only for presence.

Perhaps the resulting regime’s relatively low-level penalties – such as a $200 fine and 50 demerit points for the confirmation of one “qualifying” substance – will help it withstand legal scrutiny, but they also highlight its scientific limitations.

Other jurisdictions have taken a different path. Many have returned to behavioural assessments of impairment – the traditional field-sobriety approach of observing coordination, balance and attention.

In the United States, for instance, officers often rely on such behavioural indicators because the law there still centres on proving a driver was impaired, not simply that they had used a substance.

In the end, a test that measures presence rather than impairment risks confusing detection with prevention – and may do little to make New Zealand’s roads any safer.

Author: Joseph Boden, Professor of Psychology, Director of the Christchurch Health and Development Study, University of Otago

Source: https://www.1news.co.nz/2025/11/17/will-drug-testing-drivers-really-make-nz-roads-safer/

From: Drug Free America Foundation – 11 November 2025 19:28

          

New research from the Journal of Adolescent Health reveals critical insights about how cannabis legalization affects youth behavior, and why local policies matter more than ever. The study, led by researchers at the Public Health Institute, Kaiser Permanente and University of California, examined cannabis use among over 377,000 California high school juniors before and after the state legalized recreational cannabis retail in 2018.

The findings highlight an alarming trend: Frequent cannabis use among teens increased significantly after legalization, particularly in communities that permitted retail storefronts and delivery.

What the Research Shows:

  • Teen cannabis use increased significantly following legalization (except in areas that permitted only medical delivery of cannabis products).
  • Frequent use, defined as 20 or more days a month, grew the most, reversing a previous downwards trend and continued to increase through 2020.
  • Communities that banned retail cannabis sales entirely, consistently had lower rates of youth use, both before and after legalization.
  • Local policies made an impact. Jurisdictions that allowed storefront or delivery sales saw a significantly higher rate of use among high school juniors.

 Why Does This Matter for Prevention?

  • Teen Vulnerability– The teenage brain is still developing until the mid-twenties, making it especially sensitive to substances like THC. Early cannabis use has been linked to problems with memory, mental health disorders and increased risk of addiction.
  • Frequent use– Using marijuana on 20 or more days per month is a serious concern for teens. Regular or heavy use greatly increases the risk of dependency and the development of cannabis use disorder, potentially disrupting academic, social, and emotional growth.
  • Increased exposure– Legalization brings broader marketing, normalized use and greater access, especially when retail stores and delivery services are allowed in local neighborhoods/communities.

Recommendations for Communities:

  • Adapt or maintain retail bans to limit access and reduce normalization of use.
  • Restrict cannabis marketing, particularly near schools or on digital platforms frequently visited by young people.
  • Support local prevention coalitions to help educate families and youth about the real risks of early cannabis use.
  • Have open conversations with teens.

The Bottom Line:

Legalization does not mean safety. As this study demonstrates, when cannabis becomes more visible and accessible, youth use follows. Communities that stand firm with restrictive policies and invest in prevention can make a real difference in protecting their teens.

Source: Drug Free America Foundation | 333 3rd Ave N Suite 200 | St. Petersburg, FL 33701 US

by La Derecha Diario –  Editorial Team    17/10/2025     

Submitted by Maggie Petito, DWI – 20 October 2025

Opening remark by Maggie Petito:

This article is out of Argentina. The Cartel de los Soles has morphed, as many Latin cartels do, into differing allegiances and profit streams, it remains a fact that drug running corrupts.

Who is ‘El Pollo’ Carvajal: the Chavista spy who confessed to having financed the Kirchners with drug trafficking money

Hugo Carvajal confessed before the United States justice system that Hugo Chávez allocated millions of dollars from drug trafficking to support left-wing governments

    Hugo Armando “El Pollo” Carvajal, former chief of military intelligence for the Hugo Chávez regime, became a key figure for the U.S. justice system. Extradited from Spain in 2023, Carvajal faces charges of drug trafficking and narco-terrorism in the United States. In exchange for a reduced sentence, he decided to cooperate with the DEA and the Department of Justice, revealing how Chavismo used the state oil company PDVSA to finance left-wing movements throughout the region.

On June 25, Carvajal pleaded guilty to four drug trafficking-related offenses before Judge Alvin K. Hellerstein in the Southern District Court of New York. There, he admitted his membership in the Cartel de los Soles, a criminal organization embedded in the Venezuelan Armed Forces and considered terrorist by Washington. He also acknowledged having collaborated with Colombian guerrillas and supervised the shipment of tons of cocaine to North America.

Carvajal’s confession not only exposed the structure of Chavista drug trafficking, but also its international political financing network. In court statements and documents leaked to European media, the former spy claimed that Chavismo illegally financed left-wing movements for at least fifteen years, channeling money to allied leaders and parties in Latin America and Europe.

According to his testimony, among the main recipients of funds were Néstor Kirchner in Argentina, Lula da Silva in Brazil, Evo Morales in Bolivia, Gustavo Petro in Colombia, Fernando Lugo in Paraguay, and the Podemos party in Spain, as well as the Five Star Movement in Italy. “All of them were recipients of money sent by the Venezuelan Government,” the former military officer stated before the court.

Carvajal explained that the Bolivarian regime operated through diplomatic pouches and official flights to move the funds, coordinated by Tareck El Aissami, then Minister of the Interior, with the direct approval of Nicolás Maduro, who at that time was foreign minister. He stated that the same method was used to send money to the Kirchners.

In his most explosive testimony, Carvajal claimed that Hugo Chávez financed Cristina Fernández de Kirchner’s 2007 presidential campaign with 21 million dollars. The money allegedly arrived in Buenos Aires on 21 diplomatic flights, organized when Jorge Taiana—currently Fuerza Patria’s candidate—was Argentine foreign minister and a key figure in the political alliance between Caracas and Buenos Aires.

“The Venezuelan Government has illegally financed left-wing political movements around the world for at least 15 years,” Carvajal reiterated in a document submitted to the U.S. judge, also committing to provide unpublished documentation that would prove the route of those funds. The revelation shook both the international judicial sphere and Argentine politics, once again putting Chavista influence over Kirchnerism under scrutiny.

Who is Hugo Armando Carvajal?

Born in Puerto La Cruz in 1960, Carvajal was one of Hugo Chávez’s most trusted men. He reached the rank of major general in the Bolivarian Army, and for years led the General Directorate of Military Counterintelligence (DGCIM), where he controlled the regime’s secret operations. In 2008, he was sanctioned by the Office of Foreign Assets Control (OFAC) of the United States for his role in cocaine trafficking and his cooperation with the FARC. Since then, his name has appeared on the Clinton List, which identifies officials linked to drug trafficking and terrorism.

His political career took him to the Venezuelan Parliament as a PSUV deputy, but over time he distanced himself from Maduro and denounced internal corruption and the regime’s authoritarian drift. After breaking ranks, he fled the country and ended up detained in Spain, where he remained a fugitive until his extradition.

Today, on U.S. soil, Carvajal seeks to reduce his sentence—estimated at about 20 years—by offering evidence of how Chavismo bought political loyalties with drug trafficking money.

His testimony, which combines espionage, cocaine, and political corruption, could open a new judicial chapter in Latin America, exposing the illicit financing network that connected the Venezuelan narco-dictatorship with Kirchnerism and other left-wing governments.

Source: www.drugwatch.org

Why is the International Convention for the Suppression of Acts of Nuclear Terrorism (ICSANT) important for Small Island Developing States (SIDS)? Millions of radioactive sources are being transported and used worldwide for medical, agricultural and industrial purposes, and SIDS are not an exception. For instance, in virtually every country in the world there are radioactive sources being used for cancer treatment.

As recently stated by H. E. Ambassador Ron O. Pinder, Permanent Representative of The Bahamas to the International Atomic Energy Agency, the country is finalizing national legislation to ensure that all nuclear or radiological materials within the country’s territory are managed safely and securely. In this regard, adherence to ICSANT would help underpin these efforts.
During the Diplomatic Week 2025 “Delivering Security, Opportunity, and Justice through Diplomacy”, held on 19-23 October 2025 in Nassau, The Bahamas, UNODC discussed the Bahamas’ adherence to ICSANT, including how the Convention improves national, regional and international security. The Office also highlighted the role of ICSANT in detecting and identifying smuggled radioactive material and otherwise deterring terrorists and other criminals from using these substances. The event was opened by the Prime Minister the Honourable Philip EB Davis. It gathered over 200 delegates representing Bahamian ministers and diplomats as well as ambassadors from other countries and officials from international and regional organizations.
Ms. María Lorenzo Sobrado, Head of the Chemical, Biological, Radiological and Nuclear (CBRN) Terrorism Prevention Programme within UNODC’s Terrorism Prevention Branch spoke at the first high-level plenary session on “Emerging security threats: The Bahamas perspective”, which also featured the Honourable Wayne Munroe, KC, MP, Minister of National Security, representatives of the Royal Bahamas Police Force, the Royal Bahamas Defence Force and the Haiti Gang Suppression Force (formerly the Haiti Multinational Security Support Mission). In particular, Ms. Lorenzo Sobrado illustrated through concrete examples that the threat of terrorist and other criminal use of nuclear and other radioactive material is real for all States, not only for those ones with nuclear power programmes. She also emphasized that all States, including The Bahamas, need to establish robust and sustainable legal frameworks to counter this threat. ICSANT, to which The Bahamas is not yet party, is an essential tool at the country’s disposal to strengthen its criminal justice system and effectively prevent and combat malicious acts involving nuclear and other radioactive material.
Mr. Artem Lazarev, Programme Officer of UNODC’s CBRN Terrorism Prevention Programme, conducted a side-event on ICSANT. Through a fictional case study, he further raised awareness of relevant national stakeholders of The Bahamas on the main provisions of the Convention, benefits for the country of being party to it, and available technical and legislative assistance of UNODC.

The UNODC staff also conducted high‑level bilateral meetings on ICSANT with the following national officials: the Honourable Wayne Munroe, KC, MP, Minister of National Security; Mr. Jamahl Strachan, MP, Parliamentary Secretary, Ministry of Foreign Affairs; Her Excellency Ms. Jerusa Ali, Director General, Ministry of Foreign Affairs; and Mr. Ryan Sands, Legal Counsel, Civil Aviation Authority of The Bahamas. Among other things, the UNODC staff provided an overview of UNODC’s ICSANT‑related tools and the tailored technical and legislative assistance that the Office can offer to The Bahamas with regard to the country’s adherence to, and implementation of, ICSANT.

The country visit was conducted under a project funded by the Government of Canada.
Source: https://www.unodc.org/unodc/en/terrorism/latest-news/2025_unodc-promotes-the-international-convention-for-the-suppression-of-acts-of-nuclear-terrorism-at-the-annual-diplomatic-week-in-the-bahamas.html

Kate Dubinski · CBC News ·

Faced with teens drinking alcohol and using drugs at higher rates than others in the province, a local health unit will try to reverse the trend by using a system first developed in Iceland.

The Icelandic Prevention Model will be adapted to reflect local data and community needs, officials with Southwestern Public Health told CBC News.

“Local health status data is clear: reported use of alcohol, cannabis, tobacco, and other substances among youth is higher here than in Ontario,” said Peter Heywood, director of healthy communities at the health unit, which covers St. Thomas, Woodstock, and Oxford and Elgin counties.

More than one in three young people in that region reported using alcohol, cannabis and smoking a full cigarette for the first time in Grade 9, according to public health data, and more than half of young people reported drinking alcohol in the previous year, about 10 per cent higher than the Ontario average.

High school students will be asked to take a survey from Nov. 24 to Dec. 5, asking about substance use. They’ll be asked about their experiences in school, their communication with parents and siblings, their friendships, what they do in their spare time, how they see their mental health and what substances they use and how they perceive that use.

The results will be analysed and will guide how officials apply the Icelandic model locally, said Jessica Austin, a health promotor with Southwestern Public Health.

“The Icelandic Prevention Model was developed in Iceland by social scientists in the 90s (who) looked at factors that influence youth substance use to inform their community that had high substance rates on where they could focus their efforts to lower those rates,” Austin said.

Iceland’s teenagers used drugs and alcohol at the highest rates in Europe. Now, their rates are among the lowest.

Approach adopted worldwide

The approach has been adopted in communities around the world, including some in Canada. It focuses on prevention rather than targeting specific behaviours. Using the local data, the health unit works with community agencies, recreational facilities, faith groups, police officers, and school boards to give teens a sense of belonging.

“We know substance use is a complex issue and it requires a complex solution,” Austin said. “We’ve done a lot of work using provincial data, but now we will be able to work more effectively with the local data, to come together and get into the root causes.”

It typically takes a few years for change to happen, she added.

“I think everybody gets excited when we see the Icelandic graph sitting at one per cent for smoking rates and six per cent for alcohol-use rates, when we are sitting in the nearly 50 per cent alcohol-use rates for our youth,” Austin said.

“We would love to get down to that under the 10 per cent marker. In the short term, we want to at least get to the provincial rate.”

Source: https://www.cbc.ca/news/canada/london/icelandic-prevention-model-southwestern-public-health-9.6971289

 

Canada is betting on the Icelandic Prevention Model to reduce youth drug use.
But does it fit Canada’s opioid crisis and diverse communities?

Since 2020, Canada has been piloting a new strategy to prevent youth from using drugs and alcohol.

The strategy is based on a highly successful model pioneered in Iceland in the 1990s — one that helped cut Iceland’s youth substance use from among Europe’s highest to the lowest.

But in Canada, the effectiveness of the Icelandic model remains unproven — and some experts say Canada needs a strategy that is better targeted to Canada’s own culture.

“The [Icelandic Prevention Model] was originally developed to address alcohol and tobacco use in Iceland in the 1990s,” Leslie Buckley, chief of addictions at the Centre for Addiction and Mental Health (CAMH), told Canadian Affairs in an email.

“It was not designed with opioids or mental health in mind and doesn’t appear to incorporate trauma-informed practices,” she said.

The Icelandic model

The Icelandic Prevention Model aims to deter youth substance use by treating “society as the patient.” 

The model is implemented through entire communities by a range of organizations, including town councils, schools, health providers, youth organizations and parent groups. 

Its aim is to strengthen the social conditions that affect youth substance use, such as peer pressure, parental influence, extracurriculars and community ties. For example, parents are encouraged to have their children at home in the evenings.

In Iceland, the strategy has yielded impressive results.

Between 1998 and 2013, the share of 15 to 16-year-olds who reported getting drunk in the past 30 days fell from 42 per cent to five per cent. Daily smoking dropped from 23 per cent to one per cent, and lifetime cannabis use fell from 17 per cent to six per cent.

But its founders stress that the model must always be adapted to a country’s own culture. 

“We don’t tell people what to do, but we provide this framework, and always it has to be culturally adapted,” said Jon Sigfusson, chairman of Planet Youth, the organization that created the Icelandic Prevention Model. 

“What works in Iceland doesn’t work in Canada or anywhere else.” 

In an email to Canadian Affairs, Planet Youth emphasized the importance of understanding the unique dynamics of the community in which the strategy is being rolled out. 

“The key strategies include building a strong coalition that works in the community for the community, using survey data that looks into risk and protective factors and specific community challenges, guiding decision-making based on data,” Planet Youth’s email said.

‘The entire community’

In Canada, the Icelandic Prevention Model was first piloted in 2020 among Grade 10 students in Lanark County, Ont.

Today, it is being piloted in seven communities across the country, including in Cape Breton, N.S., Mississauga, Ont., and the Grand Erie region of Ontario.

Canada’s adoption of the Icelandic Prevention Model marks a major shift from Canada’s pre-2020 approach to substance use prevention, which relied on short-term, targeted education campaigns to help youth recognize and resist peer pressure.

“The ‘just say no to drugs’ approach does not work and has been proven ineffective time and time again,” said Sefin Stefura, project manager of the Icelandic Prevention Model in Cape Breton.

Buckley, of CAMH, says the Icelandic Prevention Model’s focus on the entire community is one of its strengths.

“One positive aspect of the Icelandic Model is that it involves an entire community — and bringing people together to work on a common goal,” she said in her email.

At the same time, experts caution that the Icelandic Prevention Model — which was first implemented in the 1990s — was not designed to address the complex challenges Canadian youth face today.

The model needs rigorous evaluation in Canada due to its “different population, different sociocultural landscape, and differing substance[s],” Buckley said.

“We cannot highlight enough the importance of evaluation in the early pilots,” she said.

No silver bullet

A recent consultation by the Canadian Centre on Substance Use and Addiction found that Canadian youth want mental health support, peer-led education and non-judgmental tools for coping with stress and trauma.

“Youth often start using substances for social reasons — to fit in and socialize more effortlessly — but often continue because they are using it to cope with stress, mental health challenges or pain,” the report says. 

Cape Breton is adapting its strategy to ensure all research and interventions put mental health, accessibility and lived experience at the forefront, says project manager Stefura. The community also plans to create a youth congress to co-lead decisions with schools and municipal leaders.

“There is really no way to separate [trauma and mental health] from primary prevention,” she said.

In Ontario’s Grand Erie region, health promoters Lina Hassen and Josh Daley say they view the Icelandic Prevention Model as a valuable framework — but only when part of a larger approach.

“We don’t pretend or believe that this is a silver bullet,” said Daley. “We know it’s a complex issue, so it’s going to have a complex solution, and we think this is complementary to what’s going on.”

“We have a local drug and alcohol strategy,” Hassen added. 

“We are recognizing the need to embed mental health components — such as training for schools and community leaders on trauma-informed care — and aligning the model with local mental health resources.”

Dagmar Morgan-Sinclair, the executive director of the team implementing the Icelandic Prevention Model in Mississauga, says the model complements, but should not replace, other targeted substance use prevention programs.

PreVenture

In Canada, one such program is PreVenture. As Canadian Affairs previously reported, PreVenture is an evidence-based Canadian program used primarily in schools and universities that helps youth identify and mitigate behavioural traits that can correlate with substance use disorders.

“Our strategy is a ‘yes, and’ to some of these individualized-focused programs,” said Morgan-Sinclair. “This is something that works in tandem.”

Buckley agrees that the Icelandic Prevention Model’s broad, community-based approach should be paired with targeted programs like PreVenture, which have been proven to work in the Canadian context.

“Health Canada says the [Icelandic] program allows for local adaptation — but most of the funded communities are in smaller or rural areas, and don’t include places with the highest rates of youth drug use like Vancouver or Toronto,” she said. 

Canada’s efforts to reduce youth substance use have, so far, been modest. Health Canada, for example, committed just $20 million to the Icelandic Prevention Model over five years, while the opioid crisis is estimated to cost the country about $40 billion a year. 

“We have not invested in primary prevention as much as we should,” said Buckley. 

“We need to consider, invest in and test these upstream prevention practices in Canada,” Buckley said.

Source: https://www.canadianaffairs.news/2025/10/19/canada-follows-icelands-lead-on-drug-prevention/

by John Suarez (612) 367-6845/ Janisset Rivero (786) 208-6056  –   Center for a Free Cuba, September 29th, 2025, Washington, DC. 

The Havana regime’s historical ties to drug trafficking and its role as an intermediary and coordinator in the hemisphere for drug trafficking into the United States have been presented in the report “Cuba: Precursor of the Cartel of the Suns. Drug Trafficking in the Hands of the State,” compiled by the Ibero-American Alliance for Global Security, the Cuba in Transition Association, and the Center for a Free Cuba.

The report has been sent to numerous organizations and entities dedicated to documenting drug trafficking and illegal activities, including the UN International Narcotics Control Board; the Global Initiative against Transnational Organized Crime; the OAS Inter-American Drug Abuse Control Commission; the International Crisis Group; the United Nations Office on Drugs and Crime (UNODC); the United States Southern Command (SOUTHCOM); among other institutions.

“The Cuban regime’s connection to drug trafficking is well documented. There is an abundance of evidence gathered from court proceedings, defector testimonies, investigations, and historical records that detail the involvement of high-ranking officials and Cuban institutions—particularly the Armed Forces—in drug trafficking.the report states:

“Drugs have served Castroism as a lethal weapon to damage American capitalist society, as corroborated by the testimony of retired Romanian general Ion Mihai Pacepa, who documented Fidel Castro and Ceaușescu’s plans during their visit to Havana in 1972 to flood the West with drugs to weaken capitalism. According to Pacepa, Castro told Ceaușescu that “drugs could do more damage to imperialism than atomic bombs.

From that date to the present, evidence of the Havana regime’s involvement in drug trafficking linked to the Colombian guerrillas, the control of Venezuela’s ports of entry and exit by Cuban military personnel to counter Plan Colombia, and the coordination of drug trafficking efforts in the region with other states such as Nicaragua with the Sandinistas under Ortega’s command and Panama during the Noriega regime, are based on direct testimony from former military personnel, former guerrillas, and drug traffickers prosecuted by the U.S. justice system, which directly implicates Cuba as a contact and support center for these illegal operations.”

“We support the international community taking direct measures to stem the flow of drugs into their respective countries and to curb the growing number of young people dying from drug overdoses. We must remember that Venezuela and Maduro bear significant responsibility for these criminal acts, but the driving force is in Havana, and the facts prove it,” said John Suárez, executive director of the Center for a Free Cuba.”

PDF version of the report downloadable here: https://www.scribd.com/document/923479521/Cuba-Precursor-of-the-Cartel-of-the-Suns

SOURCE:  Submitted by drug-watch-international@googlegroups.com On Behalf Of mlp3@starpower.net –   30 September 2025 01:04

Statement by Marcos Neto, UN Assistant Secretary-General, and Director of UNDP’s Bureau for Policy and Programme Support, at the launch of the third UNDP Discussion Paper on drug policy and development, ‘Development Dimensions of Drug Policy: New Challenges, Opportunities, and Emerging Issues’. September 17, 2025

Welcome to the side event Development Dimensions of Drug Policy: Exploring New Challenges, Opportunities, and Emerging Issues.

This is an important conversation. Drug policy remains one of the least represented issues in the 2030 Agenda and the Sustainable Development Goals. The SDGs mention drugs only in the context of substance abuse – a narrow framing.

In reality, the global illicit drug economy, estimated at more than 600 billion dollars, has profound implications for health, human rights, livelihoods, security, the environment, and development. For decades, punitive responses associated with the so-called “war on drugs” have dominated, often with devastating consequences for individuals, families, communities, and entire economies.

Today, we benefit from a growing body of evidence that demonstrates the far-reaching impacts of drug policies. We know that both production and control measures carry serious environmental costs. We know that the proliferation of new substances poses complex public health challenges. And we know that punitive approaches have led to severe human rights violations.

Since the adoption of the 2030 Agenda, UNDP has worked to broaden the understanding of drug policy, extending beyond the security frame, to a development frame with significant human and health impacts. UNDP works on rights and access to services for key HIV populations, including people who use drugs, in 97 countries. Through its partnership with the Global Fund, UNDP has supported HIV programmes in 57 countries, reaching 86,245 people who use drugs with essential services. We work to deliver the UN System Common Position on Drugs, that calls on us to work through partnerships grounded in human rights, health, and science.

And I am pleased that today we launch the third paper in UNDP’s series on the development dimensions of drug policy.

This new paper addresses today’s increasingly complex landscape:

  • the rise of synthetic drugs,
  • the diversification of drug markets,
  • the emergence of regulated cannabis and psychedelics frameworks and the risks of their “corporate capture,”
  • as well as the growing effects of drug production and control on climate and biodiversity.

The paper also proposes a way forward, highlighting innovative, pragmatic, and people-centered approaches that are evidence- and rights-based.

These approaches prioritize health, human rights, and sustainable development. They ensure meaningful community participation and remove legal barriers to prevention, treatment, care, and support services, making sure that we leave no one behind.

While there is still a lot of work to be done, around the world Member States – including my home country, Brazil – are showing that it is possible to safeguard human rights, respect minorities and Indigenous peoples, address the disproportionate impacts on women and youth, and deliver better health and development outcomes for people who use drugs.

We hope today’s conversation will inspire many more.

It is now my great honour to introduce His Excellency Ernesto Zedillo, Commissioner of the Global Commission on Drug Policy, distinguished scholar, and former President of Mexico.

 

Presentation by Commissioner Zedillo:

Development Dimensions of Drug Policy: Assessing New Challenges, Uncovering Opportunities, and Addressing Emerging Issues – September 16, 2025

This discussion paper examines how drug policy affects sustainable development, human rights, governance, health, and the environment. It underscores that punitive enforcement has largely failed, fueling violence, corruption, incarceration, and health crises, while doing little to reduce harm. In response, many countries are shifting toward evidence- and rights-based reforms such as decriminalization and harm reduction. Yet, organized crime continues to dominate markets, and debates over legal regulation are expanding.

The paper highlights both the opportunities and risks of regulation. It shows how reforms could redirect resources into health and social programmes, strengthen governance, and support sustainable livelihoods, particularly for marginalized communities. At the same time, it warns of inequities in emerging legal markets, “corporate capture”, and insufficient attention to gender, Indigenous rights, and environmental impacts.

Aimed at decision- and policy-makers, multilateral organizations, scholars, and civil society, the paper calls for a development-oriented, rights-based approach that ensures no one is left behind and aligns drug policy with the Sustainable Development Goals. It is the third paper of the series on drug policy and development produced by UNDP.

Opening Comment by DrugWatch member Maggie Petito:

It is often stated that comprehensive plans are most effective. Andean media often reports on crime profits from the transport of drugs, weapons and humans.  Additional factual reporting is needed.Few understand the profiteering by the Albanian mafia, Chinese Triads and Russian mobs. South American media does claim that Colombia [and Peru] see soaring cocaine production.Transportation and distribution yields higher profits than the actual production. Nonetheless, common sense reminds that without product, there is nothing to transport.

ARTICLE:

by    Steve Fisher, José de Córdoba and Santiago Pérez  – Wall Street Journal  – Sept. 16, 2025

From a heavily guarded mountain hideout in the heart of the Sierra Madre, 59-year-old Nemesio “Mencho” Oseguera reigns as the new drug king of Mexico, aided in his ascendance by America’s resurging love of cocaine and the Trump administration’s escalating war on fentanyl.

Oseguera spent decades building his Jalisco New Generation Cartel into a transnational criminal organization fierce enough to forge a new underworld order in Mexico, displacing the Sinaloa cartel, torn by warring factions, as the world’s biggest drug pusher.

The Sinaloans, Mexico’s top fentanyl traffickers, got caught in the crosshairs of the Trump administration, which promised to eradicate the synthetic opioid. The crackdown has left an open field for Jalisco and its lucrative cocaine trade, elevating Oseguera to No. 1.

“‘Mencho’ is the most powerful drug trafficker operating in the world,” said Derek Maltz, who served this year as interim chief of the Drug Enforcement Administration. “What is happening now is a pivot to much more cocaine distribution in America.”

Cocaine sold in the U.S. is cheaper and as pure as ever for retail buyers. Consumption in the western U.S. has increased 154% since 2019 and is up 19% during the same period in the eastern part of the country, according to the drug-testing company Millennium Health. In contrast, Fentanyl use in the U.S. began to drop in mid-2023 and has been declining since, according to data from the Centers for Disease Control and Prevention.  

For new users, cocaine doesn’t carry the stigma of fentanyl addiction. Middle-class addicts and the tragic spectacle of homeless crack-cocaine users in the 1990s helped put a lid on America’s last cocaine epidemic.

Oseguera, who grew up poor selling avocados, is making a killing from cocaine buyers in the U.S. His cartel transports the addictive powder by the ton from Colombia to Ecuador and then north to Mexico’s Pacific coast via speedboats and so-called narco subs.

U.S. forces in the Caribbean recently blew up two speedboats, including one this week, that President Trump alleged were ferrying cocaine and fentanyl from Venezuela to the U.S. Fentanyl is largely produced in Mexico, and most cocaine ships through the Pacific. All those aboard the two vessels were killed. The president also has threatened military action against Mexican drug cartels.

A video released and edited by the Mexican military showing the apprehension of a drug-laden speedboat on Mexico’s Pacific coast this year.

The U.S. has a $15 million bounty on Oseguera, but he rarely leaves his mountain compound, according to authorities. Few photos of him circulate. The cadre of men protecting Oseguera, known as the Special Force of the High Command, carry RPG 7 heat-seeking, shoulder-fired rocket launchers capable of piercing a tank, people familiar with cartel operations said.

Visitors to the drug lord’s stronghold are hooded before they embark on the six-hour car trip through terrain sown with land mines, those people said. Locations of the pressure-activated explosives are known only by members of Oseguera’s inner circle.

Oseguera’s fortunes rose after the U.S. pressured Mexico to crack down on the Sinaloa cartel, where Oseguera got his start in the trade. The Sinaloans pioneered the manufacturing and smuggling of fentanyl, an industry breakthrough that sent cartel revenue soaring and drove up the number of fatal overdoses in the U.S. For the Sinaloans, landing in the administration’s spotlight couldn’t come at a worse time.

The capture of Sinaloa cartel leader Joaquín “El Chapo” Guzmán in January 2016 and his extradition to the U.S. a year later, set in motion a precipitous decline. Guzmán’s four sons inherited their father’s empire, highly valued for its network of smuggling tunnels beneath the U.S.-Mexico border, used for moving cocaine, fentanyl and other contraband.

The sons, known collectively as the little Chapos, or “Chapitos,” shifted production resources to fentanyl, which compared with the heroin their father had brought into the U.S. by the ton is easier to smuggle and costs just a fraction to produce.

The Chapitos triggered an internecine war last year as a result of a plot against Ismael “El Mayo” Zambada, the 70-something co-founder of the Sinaloa Cartel. Zambada was forced aboard a private plane bound for the U.S. by Joaquin Guzmán, one of El Chapo’s sons, who hoped for leniency from U.S. prosecutors.

Both men were taken into U.S. custody when they landed outside of El Paso, Texas. Zambada pleaded guilty to drug-trafficking charges last month and faces a possible life sentence. Guzmán, still in custody, pleaded not guilty to trafficking charges.

Zambada’s capture led to a violent split between men loyal to Zambada’s son, Ismael “Mayito Flaco” Zambada, and those allied with the Chapitos. An estimated 5,000 people from both camps have been killed or gone missing in the conflict, along with bystanders caught in the crossfire. Mexico has sent 10,000 federal troops in the past year to the state of Sinaloa, where the federal government has been largely helpless to end the fighting.

Hemmed in by U.S. and Mexican authorities on one front, and Zambada’s men on the other, the Chapitos swallowed their pride and sought the help of Oseguera, once a sworn enemy.

Each side had something the other wanted. Oseguera agreed to meet, looking to a future where he and his Jalisco cartel would rule as Mexico’s dominant criminal enterprise.

Landmark drug deal

In December, Oseguera sat down with a top lieutenant of Iván Archivaldo Guzmán, who leads Sinaloa’s Chapito faction. At the meeting in Mexico’s western state of Nayarit, Oseguera, who was operating from a position of strength, agreed to supply the Chapitos with weapons, cash and fighters.

In exchange, the Sinaloans opened their smuggling routes and border tunnels into the U.S., said people familiar with the meeting. The Jalisco cartel previously paid hefty fees to use the tunnels to move drugs beneath the U.S.-Mexico border, people familiar with its operations said.

The agreement also divvied up the U.S. trafficking trade, these people said: The Chapitos would keep their focus on serving American fentanyl addicts. Oseguera would concentrate on cocaine and its down-market cousin, methamphetamine. The Jalisco cartel now ferries tons of cocaine and record amounts of methamphetamine into the U.S. through Sinaloan-built tunnels, as well as fentanyl, the people familiar with cartel operations said.

The Sinaloa-Jalisco agreement was “an unprecedented event in the balance of organized crime,” Mexico’s attorney general’s office said in a July report. The Jalisco cartel compares with the Sinaloa cartel at the height of its power before El Chapo’s arrest, according to the DEA’s latest drug-threat assessment.

Oseguera caught another break from the Trump administration. The president’s campaign to deport immigrants in the U.S. illegally has taken federal agents away from drug-traffic interdiction. In Arizona, two Customs and Border Protection checkpoints along a main fentanyl-smuggling corridor from Mexico have been left unstaffed. Officers stationed there were sent to process detained migrants. A senior administration official said the U.S. border is more secure than it has ever been.

Colombia is producing records amounts of cocaine, and the volume of the drug arriving in the U.S. is driving down prices, the people familiar with cartel operations said.

Cocaine prices have fallen by nearly half to around $60 to $75 a gram compared with five years ago, said Morgan Godvin, a researcher with the community organization Drug Checking Los Angeles. “The price of pure cocaine has plummeted,” Godvin said.

Tons of cocaine manufactured in Colombia are shipped from Ecuador by small crews of fishermen on a three-week voyage to Mexico.

After refueling near the Galapagos, speed-boats and so-called narco subs continue north. The Mexican navy has deployed special forces to block shipments.

The Jalisco cartel, which controls ports on Mexico’s Pacific coast, now uses routes and tunnels into the U.S. that are controlled by the sons of imprisoned drug kingpin Joaquín “El Chapo” Guzmán.

The Jalisco cartel also draws steady revenue from diverse sources outside narcotics.

The cartel acts as a parallel government in the southwestern state of Jalisco and other parts of Mexico, taxing such goods as tortillas, chicken, cigarettes and beer, security experts said. It controls construction companies that build roads, schools and sewers for the municipal governments under cartel control. 

A booming black market for fuel is another cash cow. Gasoline and diesel stolen from Mexican refineries and pipelines—or smuggled into Mexico from the U.S. without paying taxes—is sold at below market prices to small and large businesses. U.S. officials estimate as much as a third of the fuel sold in Mexico is illicit. The head of the Jalisco cartel’s fuel division is nicknamed “Tank” for his prowess at stealing and storing millions of gallons of fuel. 

The cartel profited from the passage of migrants bound for the U.S., charging them thousands of dollars each to pass through territory it controls. And in recent years, the cartel has operated more than two dozen call centers to scam senior citizens out of hundreds of millions of dollars in a vacation-timeshare fraud, according to the Treasury Department.

Family ties

Oseguera, celebrated as “El Señor Mencho” in narco-ballads, is viewed as an altruistic patriarch by some poor Mexicans living in areas controlled by the cartel, which organizes town fiestas and hands out food, medicine and toys.

In 1994, Oseguera was convicted of dealing heroin and served nearly three years in a California prison. He was deported to Mexico, where he married the daughter of the boss of a Sinaloa-affiliated gang. By 2011, he was leading his own organization based in Jalisco state.

Jalisco gunmen stormed a Puerto Vallarta restaurant in 2016 and kidnapped two Chapitos—Iván Archivaldo and Jesús Alfredo—who were celebrating Iván’s birthday. Oseguera released them after an intervention by “El Mayo” Zambada, who later became a target of the Chapitos. 

Like many of Mexico’s cartels, Jalisco is largely a family business. One of Oseguera’s brothers, Antonio, known as Tony Montana after the Al Pacino character in the movie “Scarface,” was in charge of acquiring heavy weapons, the attorney general’s report said. The brother was arrested in 2022, and in February he was among 29 drug bosses Mexico expelled to the U.S., hoping to address Trump’s demands.

Oseguera’s son, who served as a top leader in the cartel, was sentenced in Washington, D.C., this year to life in prison for drug trafficking.

Hundreds of gunmen trained by former Colombian special forces work for Oseguera, according to Mexican officials. He travels through his territory in a small convoy of armored vehicles with a team equipped to fight off aggressors until reinforcements arrive. He had a specialized medical unit built near his mountain hideout to care for his advanced kidney disease, according to people familiar with the matter.

Photos from the Mexican navy showing packaged cocaine, in a 3.5-ton seizure from a semi-submersible vessel, a so-called narco sub, caught off the Pacific coast and brought to port in Acapulco, Mexico, in June.

Two cartel accountants arrested by Mexican authorities said they were required to leave behind smartphones, Apple Watches and any device with GPS signal before traveling to meet with Oseguera, a precaution against electronic surveillance or tracking, according to the people familiar with the cartel’s operations. Oseguera has a team that manages more than 50 phones of top cartel lieutenants, people familiar with the operations said. Every week, cartel operatives gather and review phone call logs to ensure the men haven’t been speaking with enemies, security experts said. Afterward, the men get new phones. 

In 2020, more than two dozen gunmen fired more than 400 rounds at the armored car ferrying Omar García Harfuch, then Mexico City’s security chief, on the capital’s Paseo de la Reforma. García Harfuch was hit three times but survived. Two of his bodyguards and a woman headed to work were killed. García Harfuch now serves as security minister for Mexico President Claudia Sheinbaum. He is overseeing the law-enforcement offensive, backed by U.S. intelligence, that has crippled the Chapitos. 

Oseguera’s subsequent rise to Mexico’s top drug trafficker puts him in a very dangerous spot, according to a senior Trump administration official.

Source: www.drugwatch.org
drug-watch-international@googlegroups.com

 

NIH – National Library of Medicine – National Center for Biotechnology Information

2025 Oct;178(10):1429-1440.

doi: 10.7326/ANNALS-24-03819. Epub 2025 Aug 26.

by Thanitsara Rittiphairoj1Louis Leslie2Jean-Pierre Oberste2Tsz Wing Yim2Gregory Tung3Lisa Bero4Paula Riggs5Kent Hutchison6Jonathan Samet7Tianjing Li8

Abstract

Background: Rapid changes in the legalized cannabis market have led to the predominance of high-concentration delta-9-tetrahydrocannabinol (THC) cannabis products.

Purpose: To systematically review associations of high-concentration THC cannabis products with mental health outcomes.

Data sources: Ovid MEDLINE through May 2025; EMBASE, Allied and Complementary Medicine Database, Cochrane Library, Database of Abstracts of Reviews of Effects, CINAHL, and Toxicology Literature Online through August 2024.

Study selection: Two reviewers independently selected studies with high-concentration THC defined as greater than 5 mg or greater than 10% THC per serving or labeled as “high-potency concentrate,” “shatter,” or “dab.”

Data extraction: Outcomes included anxiety, depression, psychosis or schizophrenia, and cannabis use disorder (CUD). Results were categorized by association direction and by study characteristics. Therapeutic studies were defined by use of cannabis to treat medical conditions or symptoms.

Data synthesis: Ninety-nine studies (221 097 participants) were included: randomized trials (42%), observational studies (47%), and other interventional study designs (11%); more than 95% had moderate or high risk of bias. In studies not testing for therapeutic effects, high-concentration THC products showed consistent unfavorable associations with psychosis or schizophrenia (70%) and CUD (75%). No therapeutic studies reported favorable results for psychosis or schizophrenia. For anxiety and depression, 53% and 41% of nontherapeutic studies, respectively, reported unfavorable associations, especially among healthy populations. Among therapeutic studies, nearly half found benefits for anxiety (47%) and depression (48%), although some also found unfavorable associations (24% and 30%, respectively).

Limitation: Moderate and high risk of bias of individual studies and limited evaluation of contemporary products.

Conclusion: High-concentration THC products are associated with unfavorable mental health outcomes, particularly for psychosis or schizophrenia and CUD. There was some low-quality evidence, inconsistent by population, for therapeutic benefits for anxiety and depression.

Primary funding source: Colorado General Assembly, House Bill 21-1317

Source: https://pubmed.ncbi.nlm.nih.gov/40854216/

 

By Scott Wolchek –FOX 2 Detroit –  September 9, 2025 

As students return to classes, the DEA is on a mission to help prevent drug abuse on college campuses. 

Big picture view:

The Drug Enforcement Administration (DEA) emphasized that prevention is key to ensuring the health and safety of the nation’s college students, and they are actively spreading that message. The DEA is teaming up with universities across Michigan and Ohio, reaching out to let them know that resources are available.

The focus is on drug awareness because many people between the ages of 18 and 25 are increasingly becoming statistics due to unfortunate overdoses. The DEA is particularly concerned about counterfeit pills, such as ecstasy, which may be laced with fentanyl. 

What they’re saying:

They report that 50% of the counterfeit pills they seize contain a lethal dose of fentanyl. The warning is clear: stop experimenting and stay safe.

“That behavior can lead a student to go online or social media or a weird part of town to obtain what they think is a study aid which might not contain anything but filler and caffeine or worse, fentanyl. We’re just letting our campuses know these pills are out there, and they’re readily available and dangerous,” said Brian McNeal. 

“Is this an age where you see people doing, like more drugs? Uh yeah, certainly. I think more and more this era of humanity is seeing an uptick in drug usage, but I mean it’s been used throughout time and memorium,” said college student Merrick.

Merrick mentioned that he himself had not encountered any of the counterfeit pill issues that the DEA is warning about. He expressed more concern about alcohol use on campus. 

The DEA representative told FOX 2 that while some people may not listen, it’s crucial to heed this advice: don’t take any pills unless you know where they came from, or they are prescribed to you.

With the fentanyl threats all around us, it’s vital to follow the advice being discussed.

Source: https://www.fox2detroit.com/news/dea-launches-drug-abuse-prevention-campaign-college-campuses-across-metro-detroit

Press Office, Media Relations – press-office@brunel.ac.uk

The UK’s science minister, Sir Patrick Vallance, has sounded the alarm over the country’s declining investment in medicines. He warned that the NHS risks losing out on important treatments and the country could lose its place at the cutting edge of medical research if spending does not recover. It comes at a sensitive time – this year drug-makers including Merck and AstraZeneca have backtracked on plans to invest in the UK.

Vallance is correct that there is a need to encourage pharmaceutical firms to keep investing and launching new medicines in the UK. On the other side, there is a need to protect public funds from being wasted on treatments that do not offer enough benefit for their cost.

At the moment, just 9% of NHS healthcare spending goes on medicines. This is less than Spain (18%), Germany (17%) and France (15%). At a time when some experts believe the UK is getting sicker, this might come as a surprise.

But the UK is unusual among major health systems in how carefully it regulates drug spending. The National Institute for Health and Care Excellence (Nice) has, since its creation, judged new treatments not only on clinical evidence but on cost-effectiveness.

That means asking whether a drug’s health benefits – measured in quality-adjusted life years (QALYs) – justify its price compared with existing care. For most treatments the threshold is about £20,000 to £30,000 per QALY. This is not a perfect measure, but it gives the NHS a consistent way of deciding whether the health gained is worth the money spent.

The value of this approach is clear. Nice’s record shows that medicines that pass its tests have added millions of QALYs to patients in England, while also preventing waste on drugs that bring only marginal improvements at high cost.

A study published earlier this year in medical journal The Lancet found that many of the new medicines recommended by Nice between 2000-2020 brought substantial benefit to patients. But it also noted that some high-cost drugs deliver much less health gain than investments in prevention or early diagnosis could.

The study emphasises that maintaining rigorous thresholds around cost-effectiveness ensures that public funds go to treatments that really improve lives. In other words, the discipline of cost-effectiveness has protected the public purse while ensuring access to genuine innovations.

This regulatory strength is reinforced by national pricing schemes for branded medicines. These cap overall growth in the NHS drugs bill and require companies to pay rebates if spending rises too fast. In practice, this means that if total spending on branded medicines exceeds an agreed annual limit, pharmaceutical companies must pay back a percentage of their sales revenue to the Department of Health.

In recent years that rebate rate has been as high as 20–26% of sales, effectively lowering the price the NHS pays. This is made possible by the buying power of the health service.

Together with Nice’s appraisals, these measures have helped the NHS maintain relatively low medicines spending compared with many countries. At the same time, it still secures access to major advances in cancer therapy, immunology and rare disease treatment.

For a publicly funded service under constant financial strain, these protections are vital. Despite the pressure on its budget, the NHS has secured meaningful access to new therapies. For example, by March 2024, nearly 100,000 patients in England – many of whom would otherwise face long delays or rejection – had benefited from early access via the Cancer Drugs Fund to more than 100 drugs across 250 conditions.

The balance with Big Pharma

However, strict controls on price and access can have unintended consequences. If companies see the UK as a low-return market, they may choose to launch new drugs elsewhere first, or to limit investment in research and early trials here.

There is a danger that patients could face delays in receiving new treatments. Or the scientific ecosystem, which relies on steady collaboration with industry, could weaken.

Still, the answer is not to abandon cost-effectiveness. Without it, the NHS would risk paying high prices for small gains. This would divert money from staff, diagnostics or prevention – areas that often bring more health benefit per pound spent.

In such cases, raising thresholds or relaxing scrutiny would do more harm than good. Cost-effectiveness is not just about saving money. It is about fairness, ensuring that treatments funded genuinely improve lives relative to their cost.

The challenge, then, is balance. The UK should continue to hold firm on value for money, while finding ways to encourage investment. That might mean improving the speed and clarity of Nice processes, so that companies know where they stand earlier and patients can access good drugs more quickly.

It could involve reviewing thresholds periodically to account for inflation and medical progress, without undermining the principle that treatments must show sufficient benefit. And it certainly means supporting research and development through stable partnerships with universities, tax incentives and grants.

What should not be underestimated is the UK’s scientific strength. The country remains home to world-class universities, skilled researchers and an innovative biotech sector. The rapid development of the Oxford–AstraZeneca COVID vaccine showed what UK science can deliver at scale and speed.

Pharmaceutical companies know this, and many – including AstraZeneca, GSK, Novo Nordisk, Pfizer, Johnson & Johnson and most recently Moderna – continue to invest in British labs and trials because of the talent and infrastructure. Danish firm Novo Nordisk has strengthened its ties with the University of Oxford, committing £18.5 million to fund 20 postdoctoral fellowships as part of its flagship research partnership.

The UK’s approach to assessing value has won respect internationally. That discipline must be preserved. Reversing the decline in investment means creating a predictable, transparent environment for industry while maintaining the protections that safeguard patients and taxpayers alike. If done well, the UK can continue to be both a responsible buyer of medicines and a world leader in science.

Source: https://www.brunel.ac.uk/news-and-events/news/articles/The-UK-must-invest-in-medicines

From open communication to community involvement, strategies help families tackle teenage substance abuse head-on

Teenage drug use remains one of the most pressing concerns for parents across America, with recent studies showing that experimentation often begins in middle school. While the challenge can feel overwhelming, experts agree that proactive parenting and strategic interventions make a significant difference in keeping teens away from harmful substances.

Establish open and judgment-free communication early

The foundation of drug prevention starts with creating an environment where teenagers feel comfortable discussing difficult topics. Parents who begin conversations about substances before experimentation occurs give their children the tools to make informed decisions when peer pressure arises.

Rather than waiting for a crisis, families should integrate these discussions into everyday life. Talking about news stories, television shows or situations involving drugs provides natural opportunities to explore consequences and share values without making teens feel interrogated or lectured.

Research consistently shows that adolescents who believe their parents would be extremely upset by drug use are less likely to experiment. However, this doesn’t mean ruling through fear. The key lies in expressing genuine concern while maintaining an open door for honest conversations, even when mistakes happen.

Creating this safe space means responding thoughtfully rather than reactively. When teens share information about their peers or express curiosity about substances, parents who listen first and lecture less build trust that pays long-term dividends.

Monitor activities while respecting growing independence

Effective supervision doesn’t mean helicopter parenting or invading privacy at every turn. Instead, it involves knowing where teenagers spend their time, who their friends are and what activities fill their schedules.

Parents should maintain relationships with other families in their teen’s social circle. This network provides valuable perspective on group dynamics and allows adults to coordinate supervision during gatherings and events. When multiple families share expectations about substance-free environments, teens receive consistent messages across their social sphere.

Setting clear boundaries about unsupervised time, particularly during high-risk periods like after school and late evenings, helps reduce opportunities for experimentation. Studies indicate that teens with structured activities and parental awareness of their whereabouts show lower rates of drug use compared to those with minimal oversight.

Technology offers both challenges and solutions in this arena. While social media can expose teens to drug culture, monitoring apps and parental controls provide tools for staying informed without constant confrontation. The balance lies in being present and aware without becoming invasive or controlling.

Build strong connections with schools and communities

Prevention extends far beyond the home. Partnering with schools, coaches, religious organizations and community programs creates a comprehensive support system that reinforces anti-drug messages.

Parents should actively engage with school counselors and administrators to understand prevention programs and warning signs staff might observe. Many schools offer parent education nights focused on substance abuse, providing current information about trends and available resources.

Encouraging participation in extracurricular activities gives teenagers positive outlets for stress and belonging. Whether through sports, arts, volunteering or clubs, structured programs fill time productively while connecting teens with positive role models and peer groups.

Community-based prevention programs often provide peer support groups where teens can discuss challenges with others facing similar pressures. These programs normalize the choice to remain substance-free and demonstrate that saying no doesn’t mean social isolation.

Recognize warning signs and seek professional help early

Even with strong prevention efforts, some teenagers experiment with drugs. Early intervention dramatically improves outcomes, making it essential for parents to recognize warning signs without dismissing concerning changes as typical adolescent behavior.

Significant shifts in friend groups, declining academic performance, changes in sleep patterns, unexplained money issues or loss of interest in previously enjoyed activities warrant attention. Physical signs like bloodshot eyes, unusual smells or coordination problems shouldn’t be ignored.

When concerns arise, parents should consult with pediatricians, school counselors or addiction specialists promptly. These professionals can assess whether experimentation has progressed to problematic use and recommend appropriate interventions.

Many families hesitate to seek help due to stigma or hoping issues will resolve independently. However, substance abuse disorders respond better to early treatment, and waiting often allows problems to deepen. Professional support provides families with strategies tailored to their specific situation while offering teenagers therapeutic tools for addressing underlying issues driving substance use.

Source: https://rollingout.com/2025/10/13/ways-parents-protect-teens-from-drugs/

guardin-logo

 By : Ijeoma Nwanosike –  16 Oct 2025

Experts and policymakers have called on Nigeria to harness technology not only as a tool for innovation but also as a means of combating drug and substance abuse, particularly among young people increasingly exposed to both digital and chemical dependencies.

The call was made at the seventh National Conference and yearly General Meeting of the International Society of Substance Use Professionals (ISSUP) Nigeria, held at the Lagos Chamber of Commerce and Industry (LCCI), Lagos, with the theme: “Impact of Technology on Addiction: Innovations in Prevention, Treatment, Advocacy, and Research.”

Delivering the keynote address, Director of Research, Training and Head of the Drug Abuse Unit at the Neuropsychiatric Hospital, Aro, Dr Sunday Amosu, described technology as a paradox, a force for progress and, simultaneously, a trigger for new forms of addiction.

He observed that while digital tools have expanded access to healthcare and prevention resources, they have also intensified compulsive behaviours, particularly among youth navigating the pressures of modern life.

“Technology can be a double-edged sword. The same innovation that helps us track recovery and connect patients to help can also fuel gaming, gambling, and social media addictions. Our task is to strike a balance, leveraging tech for good while mitigating its harms,” Amosu said.

Representing the Minister of Youth Development, Ayodele Olawande, the Senior Technical Adviser on Youth Health and Policy Research, Dr Obinna Chinonso, commended ISSUP Nigeria for sustaining national dialogue on addiction and mental health.

He reaffirmed the government’s commitment to addressing drug and substance use among the youth, who constitute nearly 70 per cent of Nigeria’s population.

“When a young person falls into addiction, whether to drugs, alcohol, or technology, they are robbed of the clarity and creativity needed to seize available opportunities,” he said.

Chinonso outlined several initiatives, including the YoHealth Initiative, a youth-focused programme that prioritises mental health and substance abuse prevention.

He also announced the establishment of a technical working group bringing together government agencies, development partners, and civil society to strengthen preventive interventions.

He added that the ministry would collaborate with ISSUP Nigeria and other stakeholders on national sensitisation campaigns, including the forthcoming Sensitisation Against Drug Abuse, Crime, and HIV Parliament Course, in partnership with the United Nations Office on Drugs and Crime (UNODC), the National Drug Law Enforcement Agency (NDLEA), and the National Agency for the Control of AIDS (NACA).

In his remarks, President of ISSUP Nigeria, Dr Martin Agwogie, reaffirmed the organisation’s commitment to building professional capacity and promoting cross-sector collaboration to reduce drug demand.

According to him, sustainable prevention “goes beyond rhetoric” and requires systems that integrate community participation, youth engagement, and mental health support at all levels.

Chairman of ISSUP’s Board of Trustees and chief host of the event, Prof. Musa Wakil, commended the collaborative spirit of the conference, describing it as “a critical moment for aligning Africa’s response to addiction with global trends in digital health and behavioural science.”

As Nigeria faces the growing challenge of both drug and technology-related addictions, participants agreed that the future of prevention lies not only in policy but in rethinking how technology itself can be repurposed as part of the solution.

Source: https://guardian.ng/features/health/experts-policymakers-seek-tech-driven-solutions-to-combat-drug-abuse/

 

Kateena Haynes’s smile warms the room as she weaves through playing children at her feet to get to the computer room, chatting with staff as she goes. There, the walls are lined with desktop computers for kids to do their homework. A few minutes later, walking around back under the hot Appalachian sun, she notes the outstanding construction tasks for the new Boys & Girls Club gymnasium, which would officially open later that year, and beams at the progress. Haynes runs the youth development center in Harlan, Kentucky, but even if you didn’t know her official title, you’d quickly figure out that she’s the heart of this place.

During the winter of 2010, 13 of the approximately 60 kids in the Boys & Girls Club of Appalachia had a parent die of a drug overdose. One was a young girl whose father had just returned from prison and asked her to inject opioids into his arm. She said no, knowing he had already had too much.

“He wound up getting out and coming back home and overdosing in the bed with his daughter in the bed with him,” Haynes said in a 2024 interview with Encyclopaedia Britannica.

From opium to Oxy: How history set the stage for the opioid epidemic

According to the U.S. Centers for Disease Control and Prevention (CDC), more than 800,000 Americans died of opioid overdoses between 1999 and 2023. The drug that drove the initial phase of the epidemic was OxyContin, or oxycodone hydrochloride, a narcotic painkiller that can produce a euphoria similar to that of heroin. For its part in producing and distributing OxyContin, pharmaceutical giant Purdue Pharma agreed in 2025 to pay $7.4 billion to all 50 U.S. states, Washington, D.C., and four federal territories. Harlan is expected to receive at least $10 million over 18 years to establish treatment, recovery, and prevention efforts throughout the community.

In the complex evolution from the opium plant to widespread synthetic opioids, the 19th century was a critical turning point. American dental surgeon William Thomas Green Morton first demonstrated opioids’ use for anesthetic purposes when combined with ether in 1846, not long after the popular and wildly powerful pain medications morphine and codeine were isolated from opium. These drugs were widely available and could be used without a prescription. Then in the latter half of the century, heroin was synthesized; it also didn’t require a prescription until 1914.

Before 1874 all opium-related drugs were considered natural opioids. Heroin, synthesized via chemical manipulation of natural opium, was the first in a class of semisynthetic opioids. It is much more powerful than natural opioids—and much more addictive. Though heroin would be a scourge for the second half of the 20th century, the perilous power of morphine dominated the first half.

Learn more about the difference between opioids and opiates.

In 1929 the National Research Council’s Committee on Drug Addiction was created with a very specific first target: morphine. While their researchers were at work on understanding addiction and regulating the use of morphine, meperidine, the first entirely synthetic opioid, was created, ushering in a new era of increasingly potent drugs that carry massive overdose risks. At the same time access to other addictive opioids became more common. While the early-to-mid-20th century brought the use of hydromorphone and hydrocodone for pre- and postoperative pain, the distribution of opioids entered a new era in World War II.

The U.S. gave members of its military medical kits that each included single-use morphine injections to provide pain relief to injured troops waiting for advanced medical personnel. Though they had labels that read “Warning: May be habit-forming,” those labels far understated the drug’s addictive potential. After the war some medical kits were sold or stolen by those seeking morphine doses, and others who’d become addicted turned to heroin when morphine wasn’t available.

In 1947 the Committee on Drug Addiction and Narcotics was established, revamping the effort begun in the 1920s. This renewed focus on controlling the manufacture and distribution of drugs was, in part, spurred by the creation by German researchers of methadone. Methadone had shown potential to mitigate symptoms of opioid withdrawal, a potential that had yet to be fully realized. Though research funding began to trickle in, progress stalled as no stream of financial support was established until the 1960s.

That decade was known for massive societal shifts in the United States driven by the civil rights movement, feminist advocacy, and the rise of a distinct counterculture grounded in the questioning of long-held beliefs. For some, this attitude of rebellion led them to try—and in some cases become dependent on—illicit drugs. The increased use of marijuana, LSD, and eventually cocaine, heroin, and amphetamines led to crackdowns on pharmacies that distributed these drugs as well as a greater focus on prevention and treatment.

In 1962 the White House Conference on Narcotic and Drug Abuse was convened with the goal of determining how to better collect data about drug use, how to manage the use of both narcotic and nonnarcotic drugs, and what treatments could help those facing addiction. That year federally funded mental health centers were established nationally.

The next major move, the Controlled Narcotics Act of 1970, sorted drugs into five schedules, or categories, based on addictive potential and harmfulness, as well as their medical utility. Heroin, which had a spike in use in the late 1960s and early ’70s, was classified as a Schedule I drug, meaning it had a high potential for addiction and no accepted medical use. Cocaine was labeled a Schedule II drug, meaning it had some medical utility. Despite growing attention throughout the presidencies of John F. Kennedy and Lyndon B. Johnson, the official War on Drugs was not launched until 1971, when Pres. Richard Nixon declared “drug abuse” to be “public enemy number one.” The Drug Abuse Council was founded the same year, as the result of the Ford Foundation’s research, and helped to provide funding for research through 1978.

Initially the War on Drugs was praised as a long-awaited intervention for a serious public safety issue, but in hindsight many have called the effort a failure, both ethically and politically. Even with increased attention on the country’s drug problem, the use of crack cocaine soared throughout the 1980s. It was affordable and provided quick access to euphoria, and its ability to be smoked allowed people to receive smaller portions—all of which made it more cost-effective than powder cocaine, which has historically been seen as a symbol of wealth.

Instead of going after large dealers or manufacturers, Nixon’s War on Drugs led to mass incarceration because it targeted people selling relatively small quantities of drugs, which often meant prison time for young Black men in urban areas who were charged with low-level drug offenses. The War on Drugs also brought the use of mandatory minimum sentences, which disproportionately affected Black communities. Those found with five grams of crack cocaine received a mandatory five-year prison sentence. It took 100 times that amount of powder cocaine to earn the same sentence, meaning that a high-level powder dealer could receive a lesser punishment than a low-level crack dealer. Though statistics show that overall drug use is similar between white and Black communities, four in five crack cocaine users were Black. Nixon’s former White House counsel, John Ehrlichman, gave an interview in 1994 in which he explained the intentional targeting of these communities:

The Nixon campaign in 1968, and the Nixon White House after that, had two enemies: the antiwar left and black people.… We knew we couldn’t make it illegal to be either against the war or black, but by getting the public to associate the hippies with marijuana and blacks with heroin, and then criminalizing both heavily, we could disrupt those communities. We could arrest their leaders, raid their homes, break up their meetings, and vilify them night after night on the evening news. Did we know we were lying about the drugs? Of course we did.

Today many see the War on Drugs as having meted out the disproportionate impact of incarceration on historically underserved communities—a pattern that the quickly emerging opioid epidemic would only exacerbate. While the War on Drugs perpetuated stereotypes about Black communities, public response to the opioid epidemic capitalized on and furthered derogatory caricatures of rural white communities before the epidemic spread to all corners of the country.

As cocaine use grew across the United States, so did addiction. The number of cocaine users increased by approximately 1.6 million people between 1982 and 1985 alone. So when Purdue Pharma’s OxyContin (its brand name for oxycodone) was approved by the U.S. Food and Drug Administration (FDA) in December 1995, concerns about drug addiction were prevalent—which made Purdue Pharma’s marketing of OxyContin as less addictive all the more appealing, even if it wasn’t true.

The epidemic

The major problem with OxyContin extended beyond the drug itself. In fact, studies at the time of its release showed that it wasn’t more effective than other opioid analgesics on the market. What set OxyContin apart and led to the opioid epidemic was the marketing and publicity around it.

In the five years after the FDA approved OxyContin, Purdue Pharma trained more than 5,000 medical professionals at all-expenses-paid conferences, often in resort locations, to aggressively promote the drug. While there, these clinicians were trained and recruited for a Purdue Pharma speaker’s bureau that encouraged promoting OxyContin use to colleagues in environments such as grand round presentations in hospitals. The company studied physicians’ prescribing patterns in order to better tailor their sales pitch to individual doctors—especially those with the highest rates of opioid prescriptions. Though this strategy was not unique, the amount of money spent on incentives and aggressive, misleading marketing campaigns were distinctive. The company spent $200 million in 2001 alone marketing OxyContin. Sales representatives also earned bonuses that sometimes outweighed their annually salary, incentivizing them to find physicians who would overprescribe the medication.

Before this period opioids had traditionally been reserved for severe acute pain, used in the palliative care of cancer patients, for example. But Purdue Pharma’s marketing focused on expanding the conditions for which doctors would prescribe OxyContin, leading to a tenfold increase in prescriptions for pain unrelated to cancer in just five years.

This gave rise to the targeting of rural areas such as Harlan. Mining and logging in these regions often led to workplace injuries, making them hotbeds for marketing of pain relief medications. Still, that wasn’t all that made Appalachian communities vulnerable. Since the 1990s Harlan had struggled with addiction and unemployment as the coal industry declined, with more than 25 percent of Harlan county’s population of about 25,000 falling below the poverty line as of 2025. As feelings of hopelessness spread, so did the drug epidemic.

Tom Vicini, president and CEO of Kentucky drug prevention and recovery organization Operation UNITE, explained in a 2024 interview with Encyclopaedia Britannica how this can happen. In early drug roundups law enforcement discovered that people selling opioids in the area needed money to feed their addiction, he said. If they were able to buy and resell others’ prescriptions, both parties could potentially make a profit off the drug.

Why is OxyContin called “hillbilly heroin”?

As the opioid epidemic spread, it quickly became associated with Appalachian communities. Hillbilly is a pejorative term used to describe those living in often low-income rural communities in the Appalachian Mountains. Given that OxyContin had overtaken both heroin and cocaine in becoming the new face of the drug crisis, it was often referred to as “hillbilly heroin” by national media outlets.

Though there is evidence that marketing of OxyContin may have been less aggressive in cities, they were far from immune. Doctors in New York City and other large metropolitan areas received funding from opioid giants and in turn promoted their products as a gold standard for pain relief. And with TV and other advertisements repeating claims of a 1 percent addiction rate, OxyContin advertising appealed to both new patients and longtime chronic pain sufferers. As the country would learn, the actual rate of addiction is much, much higher, with some researchers reporting it as high as 26 percent.

According to the National Institute on Drug Abuse, prescriptions were the most common entry to opioid addiction throughout the 1990s and 2000s—up to 75 percent of all addictions began this way. And prescriptions became more prevalent: Annual opioid prescriptions grew from between 2 and 3 million in 1990 to 11 million by 1999. Even as the addictive potential of OxyContin was publicized, other pharmaceutical companies followed suit in manufacturing generic or brand name pills, including the firms Johnson & Johnson, Endo, Teva, and Allergan. By the 21st century, Purdue Pharma alone had made $1.1 billion in OxyContin sales, more than 20 times the sales of 1996.

With the War on Drugs rhetoric weighing heavily on people’s minds, there is intense stigma associated with drug use and dependency. Through the 1990s and 2000s, the public began to shift from viewing addiction as a moral failing to seeing it as a disease—but this change has been gradual. For some the spread of addiction to all corners of the country, including to cities’ most “elite” residents, prompted this change. Highly publicized deaths involving opioid overdoses—including that of Australian actor Heath Ledger, which was caused by an accidental overdose of a mix of oxycodone and other drugs—further influenced public perception, leading to a renewed awareness of the addictive potential of prescription drugs. Although drug overdoses have long plagued Hollywood, Ledger’s death hit the public differently in light of the rising opioid crisis, especially given OxyContin’s role in his death.

Despite shifting attitudes on the subject, a 2017 study by researchers from Johns Hopkins University found that nearly four in five people think that those struggling with addiction are themselves at fault. Stigma and feelings of shame not only incentivize individuas to hide their addiction, but it can also keep many people from getting help by generating of a network of barriers. Structural stigma, for example, includes negative views held by society that influence the creation of policies that discriminate against those struggling with addiction, such as limiting the development of local treatment centers and the availability of medication for opioid use disorder (MOUD), reducing access to quality care. Self-stigma is internalized shame that can prevent someone from seeking treatment, either because they do not feel they deserve help, are embarrassed about their addiction, or because they lack systems of support.

Long after the opioid epidemic was widely recognized in the early 2000s, rates of opioid overdoses continued an unbridled rise across the country, reaching a peak during the COVID-19 pandemic and its aftermath. In 2022 more than 81,000 Americans lost their lives to opioid overdose, likely because of interruptions in treatment and psychological hardships caused by isolation, boredom, illness, or loss of work. This was especially prominent in people 20 to 39 years old, with opioid overdoses causing more than 20 percent of overall deaths in this age group in 2022, according to a study in The Lancet. Overdoses were the largest accidental cause of death for this cohort.

The physical withdrawal symptoms associated with quitting opioids make it hard to recover from opioid use disorder. Withdrawal can range from extreme physical symptoms such as vomiting and muscle spasms to emotional symptoms such as anxiety and depression. To help people recover, there has been a growing movement to make MOUD accessible.

MOUD includes methadone, buprenorphine, and naltrexone—with the former two considered by the World Health Organization to be “essential medicines” to treat opioid use disorder. MOUD normalizes neural chemistry and blocks the euphoria of opioids and is often paired with behavioral therapy to provide a comprehensive treatment plan that addresses both the physical and psychological effects of addiction and withdrawal.

That doesn’t mean these two approaches are mutually exclusive—in fact, many people rely on multipronged approaches to treatment and community support to recover from drug addiction. In Harlan numerous peer support specialists come from their day jobs to support AA or NA group meetings, which are held every evening in a building just down the alleyway bordering a bank.

Though significant gaps still remain, the shift in understanding opioid use as a public health epidemic rather than a personal moral failing has ultimately advanced the accessibility of recovery care across the country. But meeting the urgent need for support also requires funding—and there were companies that made a lot of money as a result of mass addiction and suffering.

Lawsuits and repairing communities

Large-scale lawsuits, often initiated by state attorneys general, began in the early 2000s, when West Virginia claimed that Purdue Pharma had misled medical professionals about the addictive potential of OxyContin in their aggressive marketing of the drug. The company admitted no fault but chose to settle, paying $10 million to the state over four years, to be used for drug recovery and prevention services.

That was just the beginning. In 2007 Purdue Pharma and three of the company’s top executives were fined a total of $634 million for lying to the public about OxyContin’s risk of addiction. Later that year Kentucky sued the company, and they eventually settled, with Purdue agreeing to pay $24 million to the state. But there was a pivotal clause in that agreement: The judge granted a request to unseal the court documents, making Purdue Pharma’s strategies public and unveiling the marketing strategies that propelled the spread of addiction.

Over the next decade a series of other high-profile cases involving Purdue Pharma were settled. They were brought by state and federal governments alike, including one suit brought by Canada that took more than a decade to settle, with the company ultimately agreeing to pay $20 million to individuals and health providers. Purdue Pharma declared bankruptcy in 2019.

No single settlement was as large as the $7.4 billion agreement Purdue Pharma reached with all 50 states, Washington D.C., and four U.S. territories in June 2025, to be paid out over 15 years to support prevention, treatment, and recovery programs. This resolution to pending lawsuits came just a year after the U.S. Supreme Court overturned what would have been a $6 billion settlement paid out to state and local governments. A large portion of the $7.4 billion is to come from the Sackler family, the former owners of Purdue Pharma.

Although the bell can’t be unrung, there is a breadth of research about how best to invest these abatement funds—and early evidence shows the funding may be helping to change the future of the opioid crisis. In the United States deaths from drug overdoses decreased approximately 27 percent in 2024 from the year prior, with opioid-related overdose deaths dropping by 30,365 cases. One of the states most exemplary of this change is Kentucky, where overdose deaths decreased more than 30 percent the same year.

In Harlan these abatement funds have been used to establish a position for a case manager and advocate for Casey’s Law, which allows family or friends to commit to treatment a loved one struggling with addiction. Van Ingram, executive director for the Kentucky Office of Drug Control Policy, told Encyclopaedia Britannica that there are more mental health resources now than ever, but that there’s never enough—not just in Harlan County, but in rural America as a whole.

What is Casey’s Law?

Officially known as the Matthew Casey Wethington Act for Substance Abuse Intervention, Casey’s Law was passed by Kentucky legislators in 2004 to allow relatives or friends of someone struggling with drug addiction to petition the court for that person to be involuntarily entered into a treatment program. The decision to admit someone to treatment without their consent remains a controversial subject, and many in the recovery space believe that someone must choose to enter recovery and cannot be forced into it. Before Casey’s Law was enacted, there was no way to force an adult to get help unless they committed a crime and were required by the court to enter treatment. The law is named for 23-year-old Casey Wethington, who died of a heroin overdose in 2002. His family believed his death could have been prevented if there had been another route to court-mandated treatment.

As Haynes, CEO of the Boys & Girls Club of Appalachia, and others work to provide mental health resources for their community, Ingram said he is impressed by the growth of Harlan’s recovery community.

Said Haynes: “We started a counseling program, grief counseling, before it actually became a program of Boys and Girls Clubs of America. We were doing it first because the need was there, and we couldn’t wait for them to develop a curriculum.”

Haynes and her colleagues developed a protocol for the kids if a relative died, taking them out to dinner and keeping them occupied while the family managed funeral arrangements.

She tries to mentor these children and give them opportunities that level the playing field, Haynes told Encyclopaedia Britannica: “It’s hard for some people to see beyond these mountains…especially these kids, who are seeing their parents use drugs, and they’re just hopeless.”

Simultaneously, other Harlan organizations have been working on prevention. Both Vicini and Haynes go into schools to provide education about drugs and addiction, as well as opportunities such as field trips and mentoring partnerships to keep kids engaged in their own futures.

The city’s small size enabled the opioid epidemic to spread quickly, but the intimate, close-knit relationships that the community provides have also allowed it to be a safe haven for many, including some who came there for recovery and never left.

With a combination of local efforts led by the city’s drug court and various recovery programs, including some focused on job reentry, Harlan has become an example of what an engaged recovery community can look like—and advocates believe that overdose rates are declining because of it.

Overdoses are decreasing on the national level, as well. According to a study published in the Journal of the American Medical Association, 2023 marked the beginning of “a new wave of sustained deceleration [in overdose rates]…after 2 decades of increase.”

The new wave: Dangers of fentanyl

The epidemic entered a new—and perhaps even deadlier—phase with the introduction of fentanyl. Though it has been around since 1959 as a pain reliever, illicitly manufactured fentanyl has grown increasingly popular since it became a major part of the U. S. illegal drug market in 2013. Drugs such as methamphetamines or cocaine are increasingly laced with fentanyl. In 2022, 6 out of every 10 of the millions of fentanyl-laced fake prescription pills collected by the U.S. Drug Enforcement Administration (DEA) contained a potentially lethal amount of the opioid, up 50 percent from the year before. Though a small segment of people who use drugs seek out fentanyl, many of those buying laced pills are unaware of its presence until it is too late.

Fentanyl is the one of the most potent pharmaceutical opioids and is 100 times more powerful than morphine. A dose of the drug equivalent to just five to seven grains of salt can be lethal, which is partially why it’s responsible for 70 percent of overdose-related deaths. And growing numbers of illegally obtained drugs are laced with fentanyl because its potency allows smaller doses of the pure drug to be sold while providing the same level of euphoria and even higher addictive potential, increasing both profits and demand. Even if it puts customers in danger, the money outweighs the risk for some sellers.

In a February 2025 U.S. Senate hearing, Sen. Dick Durbin of Illinois spoke about the growing risk of fentanyl:

In just a decade this synthetic opioid [fentanyl] has emerged as the deadliest drug in American history. All it takes is two milligrams—that’s a fraction of the size of a penny—to cause an overdose. It is so cheap that dealers are lacing lethal amounts into street drugs like cocaine and heroin, and their buyers are none the wiser.

Yet if communities can harness the growing concern about fentanyl for change, it may give a second chance to those struggling with substance use disorder. Since 2022 Harlan county has held an annual drug summit to bring together more than two dozen exhibitors with a focus on continuing to bring down overdose rates, even in the face of fentanyl.

Along with increased efforts to provide those struggling with addiction transitional housing, reemployment, and improved treatment accessibility, Harlan and other communities hit hard by opioids have another key tool: love.

“There’s people that came here for treatment and never left, because they were loved,” said Dan Mosley, Harlan county judge executive. “That’s truly what makes our place special.”

Source: https://www.britannica.com/topic/How-the-Opioid-Crisis-Devasted-Families-Communities-and-Ultimately-a-Country

 

United Nations

United Nations – Office on Drugs and Crime

07 October 2025

Practical, Digital and Tailored to Help You Grow

The United Nations Office on Drugs and Crime (UNODC) has officially launched its dynamic new Learning and Innovation Programme and with it, the new powerful digital training platform called SPARK.

SPARK brings flexible, high-impact learning to professionals worldwide – from bustling capitals to remote field stations.

In many low-resource or remote settings, criminal justice institutions face significant challenges, such as fragmented access to training, language barriers and geographical isolation. As a result, many practitioners lack training altogether, while those who do receive it often rely on sporadic training or outdated courses, leaving them underprepared for rapidly evolving threats.

UNODC, through the eLearning platform SPARK, addresses these challenges by providing multilingual online and offline courses and fostering a global community of practice. This approach bridges gaps and makes knowledge on justice more accessible worldwide.

Meet SPARK: Learn Anytime, Anywhere

This new Programme reflects a growing institutional shift toward digitalization and innovation not just as tools, but as essential strategies for building safer, more secure societies.

The Learning and Innovation Programme now focuses on three core areas:

  1. Digital training delivery across all UNODC thematic areas, i.e. the world drug problem, transnational organized crime; terrorism; corruption; and criminal justice.
  2. Pedagogical support to enhance the quality and impact of training provided by partners;
  3. Digital transformation for the internal operations and processes of criminal justice institutions and academies.

“This Programme introduces a new approach to capacity-building,” said Aimée Comrie, Chief of UNODC’s Crime Prevention and Criminal Justice Section. “It is practical, digital and tailored to help institutions grow stronger through innovation.”

At the heart of the Programme is SPARK – a powerful, modern digital learning platform that offers cost-effective, flexible interactive and accessible training tools for professionals across the criminal justice system. It includes self-paced eLearning courses, with interactive scenarios and simulations, as well as eClasses, which support both in-person and virtual training formats. Knowledge hubs, including webinars, online libraries, forums and podcasts are also featured. Moreover, content is localized, tailored to regional, national or local needs. 

Digital Transformation: From the Ground Up

Many criminal justice institutions, particularly in remote or underserved regions, continue to face serious barriers to modernization: limited internet access, power outages, outdated administration systems and low levels of digital literacy. These challenges not only hinder operational efficiency but also limit the ability of institutions to adapt to rapidly changing criminal justice threats.

The Programme directly addresses these obstacles by helping institutions digitalize core operations such as data management, administration, communication and training coordination. The Programme also providers basic digital literacy training, from device operation and email use to safe web navigation and online collaboration.

“Digital transformation is not just about technology – it is about empowering institutions to function more effectively, securely and inclusively,” said Nicolas Caruso, Head of the Learning and Innovation Programme. “By addressing infrastructure and skill gaps, we are helping justice institutions become more resilient and better equipped to meet the need of their communities.”

To ensure learning reaches even the most remote locations, the Programme has introduced  Mobile Training Units (MTUs) – portable kits containing a server, laptops and a router that can run for five hours without external power and be deployed in just 20 minutes. The MTUs have been deployed in 30 locations across West, Central and Eastern Africa, Latin America, South Asia and Southeast Asia, and North Africa and the Middle East.

Moreover, over 60 eLearning Centres have already been established globally, blending in-person instruction and creating local hubs for outgoing training.

Source: https://www.unodc.org/unodc/en/news/2025/October/unodc-ignites-innovation-with-new-learning-programme-and-spark-elearning-platform.html

by Ryan Hesketh – Talking Drugs – Posted on September 15, 2025

In November, the World Health Organisation (WHO) will issue its long-awaited recommendation on whether the coca leaf should remain listed under the UN’s most restrictive drug controls.

For decades, the coca leaf has been treated in international law as little more than raw material for cocaine. The 1961 Single Convention on Narcotic Drugs, following the advice of a deeply flawed 1950 WHO report, placed coca in Schedule I, equating its potential harm from use with that of heroin. This decision criminalised traditional use by Indigenous peoples in the Andes, despite millennia of practice, ignoring both its cultural and medical significance. 

Now, with WHO experts due to report their findings in September, attention is turning to whether the organisation can finally correct the record.

Critical timeline

Bolivia’s government initiated the review in 2023, arguing that coca’s scheduling was based on flawed information and infringed on indigenous rights. Since then, the WHO has tasked independent experts with conducting research on coca, its harms, and the potential impacts of change. Those experts are due to report their findings to the Executive Committee in late September, a crucial step on the pathway to potential change.

From there, the Expert Committee will meet in late October, finalising its report and recommendation in time for member states to consider ahead of the UN Commission on Narcotic Drugs’ (CND) reconvened session in December. The formal vote on coca’s scheduling, however, won’t take place until March 2026 in Vienna.

Luis Arce, the former president of Bolivia, holding coca leaves in 2022. Author: Vice Ministry of Communication of Bolivia

Uncertain outcomes

There are essentially three potential outcomes from the review. First, no action. Either the WHO makes no recommendation, which would result in no possibility of a vote, or states vote to maintain coca’s current Schedule I classification. Few expect the WHO to recommend keeping coca in its current schedule. “It’s hard to imagine they’d come to the conclusion that coca belongs where it is,” according to John Walsh, Director for Drug Policy and the Andes at the Washington Office on Latin America (WOLA).

If the review recommends a change in Coca’s scheduling, it would likely move down to either a Schedule II or III – still keeping its classification as a ‘narcotic drug’ subject to most treaty provisions. However, such a move would allow for certain traditional uses of coca and could be seen as a political compromise between those favouring full rescheduling and those favouring prohibition. This would create a clear difference in the scheduling for Coca and cocaine, similar to how opium products and the opium poppy are scheduled. Opium poppies are in Schedule II, while heroin is in Schedule I, reflecting the differing harms of the plant and its derivatives. Though rescheduling might be the most politically expedient outcome, and may align more closely with the UN’s Declaration on the Rights of Indigenous Peoples, it would still be very short of full removal, according to Walsh.

Finally, the result hoped for by many states and drug policy reform advocates: coca could be completely removed from the drug control treaties. This would mean that coca “would no longer be considered a controlled substance. It would open the way to legal natural commerce,” according to Walsh. 

While the size of such a market is hard to estimate, its significance would be massive. Coca teas, flours, and medicinal extracts already circulate domestically in the Andes – only legally within Bolivia as the country had left and re-joined the UN drug control conventions in 2013 – but international markets remain blocked by treaty restrictions. 

Yet there are also risks. Walsh cautions: “There’s a concern, even among those who want coca removed, that those who have guarded the tradition could be undermined.” Comparisons to the cannabis market loom large, where capital from the Global North has quickly moved into spaces originally meant by marginalised communities. The vision of a future un-criminalised market for coca opens future concerns, such as control mechanisms that avoid biopiracy and endorse fair benefit-sharing, particularly with communities that have been destroyed by the plant’s prohibition. The Nagoya Protocol, which addresses protections against the exploitation of genetic resources and Indigenous knowledge, is often cited as a model for future control.

Even in the case of full removal, coca wouldn’t be completely free of international prohibition. “Coca destined to become cocaine would still be illegal; that wouldn’t be optional,” according to Walsh. Better controls to determine the end use of coca would have to be developed.

Politics and removal

In theory, removing coca from Schedule I requires only a simple majority of CND member states. In practice, however, bloc politics loom large. “As a formal matter, there’s no veto. But in a practical matter, the EU looms large,” Walsh explains, given the bloc’s significant role in driving global demand for cocaine. If European states vote together against rescheduling, the motion would be unlikely to pass. However, if the EU allows states to vote individually, the change is much more likely to happen.

The United States’ position is also critical. As Walsh puts it, “It would be difficult to imagine if the US would be supportive of removing coca entirely.” But, though the US was once the world’s biggest supporter of draconian drug laws, its international influence may be waning. The current administration’s defunding of global aid, much of which supported harm reduction and drug prevention programmes, have reduced the US’ ability to enact soft power internationally. President Trump’s “transactional” politics, according to Walsh, may be a signal to countries that they can go their own way on policy while the US is pursuing a more isolationist approach to international relations.

Russia, too, will be notably absent. Having not achieved sufficient votes to remain part of the CND in April 2025, Russia will not be voting on UN drug-related matters from 2026 onwards. Walsh said that “Russia has taken the mantle from the US as ‘drug warrior’” and could’ve stood staunchly against coca’s reclassification. Their absence, therefore, may open new horizons.

The coca review is primarily supported by Bolivia and Colombia, with Canada, Czechia, Malta, Mexico, and Switzerland publicly supporting their position. Some coca-producing nations, notably Peru, are not in favour of reclassification. The country’s drug control agency, DEVIDA, recently argued that reclassifying coca “could become a perverse incentive to increase its diversion to the production of cocaine,” as well as increasing deforestation and food insecurity, especially for indigenous people.

But for some, Peru’s lack of support for the review has more to do with its political priorities than any attempt at harm reduction. “Peru’s denial to support this is indeed very odd, but is a reflection of the kind of political regime it is living under,” says Pien Metaal of the Transnational Institute (TNI). “The Boluarte government is the typical white Lima elite that has ruled Peru over the past decades, with no connection to the hearts and minds of the Peruvian people.”

Indigenous resistance

The roots of the current review go back to decades of Indigenous advocacy. The UN Declaration on the Rights of Indigenous Peoples recognises the right to maintain and protect traditional medicines and cultural practices. Yet international drug treaties continue to criminalise coca chewing and related practices in many countries. 

“There has never been a credible medical or scientific basis for the prohibition of coca leaf,” according to Metaal. “Its inclusion in the 1961 Convention was a political act, not a scientific one.”

Underlying the review is a reckoning with the colonial assumptions that shape global drug control to this day. The 1950 WHO study that underpinned coca’s prohibition dismissed Indigenous practices as harmful and regressive, ignoring evidence of its benign cultural role. For many advocates, the current review is an overdue opportunity to correct that record. As Metaal argues, “This is not just about drug policy. It is about dignity, cultural survival, and Indigenous rights.”

Impending Change

For coca-using and growing communities, the implications are immediate. Continued criminalisation undermines cultural practices, justifies militarised eradication, and fuels human rights abuses. Removing the plant from international control could finally legitimise its traditional use, defund eradication policies, and unlock new economic opportunities grounded in heritage rather than prohibition.

As Walsh reflects: “In five years, I hope that we’re able to see a genuinely growing understanding of how natural coca products can really bring a lot of help to people around the world. I hope those markets can open up and can be beneficial to those communities that are most identified with coca.”

With the WHO’s deadlines fast approaching, the question is whether the international drug control system can rise to meet the moment—or whether it will once again fall back on outdated prejudices, leaving another generation of Indigenous peoples to fight for recognition of what they already know: that prohibition, not the coca leaf, is the problem.

===============================

Source:  https://www.talkingdrugs.org/upcoming-who-coca-review-a-turning-point-for-global-drug-policy/

by Jack Fenwick – BBC Political correspondent – 16 September 2025

Hilary’s son Ben died from a heroin overdose in 2018, but his death was never included on official opioid death statistics

More than 13,000 heroin and opioid deaths have been missed off official statistics in England and Wales, raising concerns about the impact on the government’s approach to tackling addiction.

Research from King’s College London, shared exclusively with BBC News, found that there were 39,232 opioid-related deaths between 2011 and 2022, more than 50% higher than previously known.

The error has been blamed on the government’s official statistics body not having access to correct data and it is understood ministers are now working with coroners to improve the reporting of deaths.

A former senior civil servant said fewer people might have died if drug policies had been based on accurate statistics.

The number of opioid deaths per million people in England and Wales has almost doubled since 2012, but this new study means the scale of the problem is likely to be even greater.

Researchers from the National Programme on Substance Use Mortality at King’s used data from coroners’ reports to calculate a more accurate estimate of opioid-related deaths.

Opioids include drugs such as heroin that come from the opium poppy plant, as well as synthetically-made substances like fentanyl.

The Liberal Democrats have said the government needs to “urgently investigate” how the error was made.

The reliability of the Office for National Statistics (ONS) data relies on coroners naming specific substances on death certificates, something which often does not happen.

Specific substances such as heroin are instead sometimes only included on more detailed post-mortem reports or toxicology results, which the ONS does not have access to.

Government data on overall drug deaths, which does not name specific substances, is not affected by the error, but ministers’ decision-making is generally influenced by the more granular statistics.

The body that oversees police commissioners says correct data on opioid deaths could have led to more funding and better treatment for front-line services such as police forces and public health.

Sir Philip Rutnam, who was the most senior civil servant at the Home Office between 2017 and 2020, told the BBC it was “quite possible” that fewer people would have died, if the government’s drug policies had been based on accurate statistics.

He told BBC Radio 4’s PM programme: “It really does matter, first of all the level of attention given to these issues, but then specifically it will affect decisions on how much funding to put into health-related programmes, treatment programmes, or into different bits of the criminal justice system.”

“My son’s death is one of thousands missed from official stats”

Ben was 27 when he died from a heroin overdose in 2018, but his death was ruled as “misadventure” and was never included on the official opioid death statistics.

His addiction began with cannabis when he was a teenager and progressed to using aerosols and eventually heroin.

“Ben was just a very kind person. We miss him, we all miss him every day,” said his mother Hilary.

At one point, she said Ben appeared to “turn a corner”.

He was awarded a place in a rehab facility, but shortly before he was set to move in, Hilary got the phone call she had always dreaded.

“I think what happened is, he wasn’t using,” she said. “They think probably about three months and his tolerance had gone down.”

Ben’s family believe that different treatment and support for drug addicts could have helped him.

Dr Caroline Copeland, who led the new research, said drug policies “will not have the desired impact unless the true scale of the problem is known”.

She added: “We need to alert coroners to the impact that not naming specific drugs as the cause of death has on the planning and funding of public health policies.”

The research, which has been peer-reviewed and published in the International Journal of Drug Policy, focused specifically on opioid deaths, but similar undercounts are thought to exist in data about deaths from other drugs too.

Further work by King’s College London has found that 2,482 cocaine-related deaths have also been missed off ONS statistics over the last 10 years.

David Sidwick, the drugs lead for the National Association of Police and Crime Commissioners, told the BBC the organisation would “be pushing hard” for more treatment funding, in light of the faulty statistics.

Mr Sidwick, who is also a Conservative police and crime commissioner, said more accurate data would lead to “better decisions about the amount of funding required for treatment” and suggested “new treatment methods” such as buprenorphine, a monthly injection that can help heroin users overcome addiction.

Helen Morgan, the Liberal Democrat health spokesperson, said: “I dread to think of the lives that may have been lost due to damaging policies based on faulty stats.”

She added: “The government now needs to step up, launch an investigation and ensure that the ONS is given access to the data it needs so that it can never make this error again.”

The ONS, which helped with the research, said it had warned that “the information provided by coroners on death registrations can lack detail” on the specific drugs involved.

A spokesperson added: “The more detail coroners can provide about specific drugs relevant to a death will help further improve these statistics to inform the UK government’s drug strategy.”

The flaw in the ONS system is not present in Scotland, where there are no coroners and where National Records Scotland (NRS) is responsible for collating official statistics.

Unlike the ONS, the NRS does receive more detailed pathology reports, but differences in how deaths are reported across the UK make it difficult to compare.

The opioid undercounting raises further questions about the under-fire ONS, which has been accused of failing on several statistical fronts recently.

Data sets on job markets and immigration have been criticised and earlier this year a government review said the ONS had “deep-seated” issues which needed tackling.

A spokesperson for the Department of Health and Social Care said: “We continue to work with partners across health, policing and wider public services to drive down drug use, ensure more people receive timely treatment and support, and make our streets and communities safer.”

 

Source:  https://www.bbc.co.uk/news/articles/cg7dzmyjrjzo

 

by Boston Herald editorial staff – September 17, 2025

There’s a renewed push to legalize overdose prevention centers  on Beacon Hill, with advocates touting supervised drug use as harm prevention.

That depends on how one defines harm.

At these centers, trained health care workers would supervise individuals who use pre-obtained illicit drugs — and they could intervene and prevent fatal overdoses.

Yes, addicts could avoid overdosing and live another day — another day in which they’d steal or prostitute themselves to buy drugs, another day in which opioids could further damage their mind and body, and another day to stumble through the degradation of a life ruled by drugs.

The real winners? Drug dealers and traffickers. Their clientele may have access to rehabilitative services through these centers, but that cry for help may not come for a long time. Meanwhile, they are willing customers for those “pre-obtained” drugs.

In these progressive parts, the law is to be followed except if you don’t like it. Therefore, these proposals would provide legal protections for workers, drug users accessing the facilities, government officials and other stakeholders. Because the drugs being injected are, of course, illegal.

Rep. Mindy Domb, co-chair of the Joint Committee on Mental Health, Substance Use and Recovery, said Massachusetts last year recorded fewer than 2,000 fatal overdoses, breaking a grim years-long trend.

Yes, naloxone is an amazing thing, and distribution of Narcan has saved many lives from overdoses. But making drug addiction safer with the added net of Narcan is like putting a bandage on a deep wound.

One can’t fight the opioid crisis by prolonging addiction. Keeping up the demand for drugs fuels the supply and the crime that comes with trafficking. And the drug market only gets worse.

Nitazenes have entered the chat.

Last year, a state-funded drug checking program in Massachusetts has found opioids up to 25 times stronger than fentanyl, according to WBUR. In a bulletin, public health officials say the number of drug samples testing positive for nitazenes is small — but growing quickly.

“The more that we crack down on things like fentanyl and heroin, that’s going to lead to the rise of other things that are infiltrating the drug supply,” said Sarah Mackin, director of harm reduction at the Boston Public Health Commission.

“Nitazenes is just the newest thing to come through,” after xylazine, the animal tranquilizer found in 9% of overdose deaths in 2023.

However, an investigation of records from hospital emergency departments published by the JAMA Network found it often takes more doses of naloxone to reverse an overdose when nitazene is involved than it would take to reverse a fentanyl overdose. Further study is needed.

Keeping the drug cycle going, however “safely,” isn’t a step in the right direction, it’s just another foot forward on the addiction treadmill.

We need addiction reduction, stat. We need to fund programs such as Boston Medical Center’s Faster Paths to Treatment, its substance use disorder urgent care program. And we need more of them.

True harm reduction comes from helping addicts get clean so they can live full, productive lives.

Source: https://www.bostonherald.com/2025/09/17/editorial-rehab-is-the-best-harm-prevention-for-addicts/?

 

ABU DHABI, 3rd August 2025 (WAM) — The International Society of Addiction Medicine (ISAM) has praised the federal decree-law issued by President His Highness Sheikh Mohamed bin Zayed Al Nahyan establishing the National Anti-Narcotics Authority, describing it as a vital and effective tool that enhances the UAE’s quality of efforts in combating narcotic drugs and psychotropic substances and eliminating their sources.

In a statement, ISAM affirmed that the decree issued by the UAE President reinforces the country’s comprehensive and precise approach in tackling the global threat of drug abuse.

It stated that the UAE has continually updated its legislation to combat narcotics, while simultaneously advancing its security, prevention, treatment and awareness efforts, which have significantly contributed to curbing this menace.

Dr. Hamad Al Ghafri, President of ISAM and Board member of the American Society of Addiction Medicine (ASMA), stated that the establishment of the National Anti-Narcotics Authority provides a holistic framework for developing policies and strategies to combat drug abuse, including mechanisms for prevention, treatment and rehabilitation.

He added that the legal powers granted to the authority would play a key role in enhancing the UAE’s national efforts and institutions, which work relentlessly to eliminate drug sources and confront those who target the country’s youth.

Dr. Al Ghafri explained that the authority’s mandate is built around several core pillars, including reducing both the supply and demand for drugs by tracking and dismantling trafficking networks, bolstering treatment and rehabilitation systems to reintegrate recovered individuals into their families and communities, and advancing legislative frameworks alongside dedicated research.

“These efforts will support community-based prevention initiatives, establish a unified national monitoring system, and promote international collaboration in training and capacity-building. These pillars are central to achieving an integrated approach that combines preventive, security and therapeutic dimensions to effectively tackle all facets of the drug issue,” he added.

Dr. Al Ghafri reaffirmed ISAM’s commitment to supporting all initiatives and programmes related to combating narcotics and psychotropic substances, while enhancing cooperation and coordination and adopting efforts that contribute to building safe and drug-free societies.

Source: https://www.wam.ae/en/article/bl0dfij-isam-praises-uae-presidents-decree-law

new study from researchers at the Johns Hopkins Bloomberg School of Public Health sheds light on how people who inject drugs (PWID) are responding to the growing instability and danger in the U.S. illicit drug supply. Despite facing structural vulnerabilities, participants in the study demonstrated a keen awareness of changes in drug quality and content, and many are taking proactive steps to reduce their risk of overdose, injury, and other harms.

Published July 24, 2025, in the journal Health Promotion International, the qualitative study explores the experiences of 23 PWID in Baltimore City, where a growing number of opioid-related deaths and the emergence of new, harmful adulterants like xylazine have made drug use increasingly perilous. Participants reported encountering potent and unpredictable drug combinations and described cognitive, behavioral, and social strategies they use to navigate this new reality. Notably, the paper’s publication comes just two weeks after a mass overdose in Baltimore’s Penn North neighborhood sent dozens of people to the hospital in the span of a few hours and tests revealed unfamiliar ingredients.

“We found that people who inject drugs are not indifferent to the risks they face,” said lead author Abigail Winiker, PhD, MSPH, an assistant scientist in Health Policy and Management and program director for the Bloomberg Overdose Prevention Initiative. “They are making conscious decisions every day to protect their health, whether that’s testing a small dose, avoiding injecting alone, switching to less risky methods of use, or sharing safety information with peers. These are intentional harm reduction strategies grounded in knowledge and a desire to stay safe.”

The U.S. continues to grapple with a historic overdose crisis, with over 107,000 deaths reported in 2022 alone. Fentanyl and its analogs now dominate the opioid supply, but new substances, often unknown to users, are increasingly present. Participants in the study described a “wildcard” market where real heroin has been replaced by unpredictable blends, sometimes laced with benzodiazepines, dissociative agents, or tranquilizers like xylazine, which are not meant for human consumption.

The uncertainty has led to intense fear and physical harm among PWID, with many recounting a range of adverse reactions from illicit substance use, including blackouts, seizures, severe wounds, and overdose. Despite the increasing risk associated with these drug market changes, most participants reported having no access to a reliable source of information about the composition of the drug supply, making it challenging to adapt in the face of new additives. Most knowledge about specific risks or harmful batches was passed on through word of mouth, which could perpetuate rumors and the spread of misinformation.

Individual and Collective Adaptations 

The study highlights the wide array of harm reduction strategies participants use to mitigate risk. Cognitively, many indicated thinking about their drug use in terms of personal health and family responsibilities, with some expressing a motivation to seek treatment or abstain from use entirely in the face of an increasingly risky drug supply.

Behaviorally, PWID described strategies such as taking smaller test doses, sniffing instead of injecting, and having someone present who could administer naloxone if needed. Socially, trust played a critical role; participants emphasized returning to known sellers who warned them about potent batches and relying on peer networks to spread information about adverse events or dangerous batches in circulation. 

“These strategies reflect a deep sense of agency and adaptability,” said Winiker. “Our findings debunk the dangerous myth that individuals who use drugs are reckless or disconnected from their health. This false narrative perpetuates stigma and limits our ability as a society to recognize the incredible resilience and strength of people who use drugs.” 

Policy and Programmatic Implications 

The authors argue that these findings should inform more responsive public health policies and harm reduction programming. While fentanyl test strips can be an effective intervention, many participants noted that fentanyl’s presence is now expected, but what they fear are the unknown additives they cannot identify or test for, such as those that were found in the case of the mass overdose two weeks ago. Universal drug checking services, real-time supply surveillance, and mobile harm reduction outreach are critical next steps, the study concludes.

The research also points to the urgent need to remove structural barriers to harm reduction. In many states, drug checking equipment is still considered illegal paraphernalia. Criminalization and stigma continue to limit access to lifesaving services, especially among those who are unhoused or medically underserved. 

“People who inject drugs are doing their part to reduce harm,” said Winiker. “It’s time to reform our systems so they stop making it harder for them to do so, by legalizing drug checking, ensuring individuals with lived experience have leadership roles in overdose prevention and response efforts, investing in safer supply programs, and ensuring that stigma and punitive laws don’t block access to care.”

The study was conducted as part of the SCOPE Study, a project led by Susan Sherman, PhD, MPH, to design an integrated drug checking and HIV prevention intervention. It was supported by the National Institute on Drug Abuse and reflects growing interest in how PWID are adapting to the post-fentanyl era.

Source:  https://publichealth.jhu.edu/2025/in-the-face-of-a-volatile-drug-supply-people-take-harm-reduction-into-their-own-hands

by Shane Varcoe – Executive Director for the Dalgarno Institute, Australia – Jul 23, 2025

Alcohol affects 15 of the 17 United Nations Sustainable Development Goals, yet remains one of the most overlooked barriers to global progress. Behind the marketing messages and cultural acceptance lies a stark reality: alcohol is a Group 1 carcinogen causing seven types of cancer, with no safe level of consumption.

This week on the Unnecessary Harm Podcast,  we welcomed Kristina Sperkova , President of Movendi International , a global network of over 170 organizations across 63 countries working to reduce alcohol-related harm. Kristina shared powerful insights from her decade of leadership at the forefront of international alcohol policy advocacy, including her recent work at the World Health Assembly.

Kristina reveals how alcohol undermines everything from poverty reduction to gender equality, the predatory tactics of Big Alcohol at UN meetings, and the groundbreaking policy wins that are reshaping how the world views alcohol taxation and regulation.

 Key Takeaways From This Episode 

  • Massive Global Impact: Alcohol directly affects 15 of 17 UN Sustainable Development Goals, from perpetuating poverty cycles to fueling intimate partner violence (50-80% of violent acts are alcohol-related).
  • Environmental Devastation: Producing one liter of beer requires 270 liters of water, highlighting alcohol’s massive environmental footprint through water depletion and agricultural monocultures.
  • Cancer Connection: Since 1988, alcohol has been classified as a Group 1 carcinogen alongside tobacco and asbestos, yet public awareness remains dangerously low.
  • Industry Deception: Big Alcohol uses front groups, creates dependency through corporate partnerships, and spreads lies about employment impacts and illegal production to derail effective policies.
  • Policy Solutions Work: WHO’s “best buys” – availability restrictions, marketing bans, and public health taxation – are proven, fast-acting interventions that reduce consumption and generate revenue.

Recent Victory: After 10 years of advocacy, alcohol taxation was officially recognised as a source of domestic resource mobilisation at the Financing for Development conference – a major breakthrough for global policy.

Source: https://www.linkedin.com/pulse/alcohols-global-impact-fight-evidence-based-policy-shane-varcoe-fmc8c

 

OPENING REMARK BY NDPA:

Dianova presents itself as a “Swiss NGO recognized as a Public Utility organization, committed to social progress”. Examination of their publications places them as an organisation which is less committed to primary prevention than to reactive approaches, such as harm reduction. A telling quote in this context comes in their publication entitledBetween Music and Substances: a Look at Drug Use at Festivals” they introduce this by saying Drug use is a common occurrence at most music festivals: how can we promote self-care and harm reduction among participants?”there is no mention of prevention as a policy option.

In their ‘history’ Dianova take a position found not infrequently in some other other critics of prevention i.e. any prevention program which does not achieve 100% success is deemed a failure … but no such assessment is made of reactive or accepting policies.

In this publication they dismiss the ‘Just Say No’ program as “…focusing mainly on white, middle-class children, it simply pointed the finger at others, particularly black communities, who were held responsible for the problem.” And yet immediately below this statement they include a photo of a White House ‘Just Say No’ rally, with Nancy Regan surrounded by black youngsters.

Dianova make judgemental remarks – without supporting evidence – in several places, and NDPA take would issue with several of these, but we have elected to retain this paper complete with their judgemental remarks, to illustrate their position on the ‘history’ as they see it.

by the Dianova.org team – 

From the early 20th century to the present day, an overview of the origins of drug use prevention, past mistakes and the current situation in this field

By the Dianova team – Over the past 40 years, prevention has become a key focus of public intervention in many areas, including responses to social issues such as alcohol and other drug use. Prevention strategies are now most often part of a comprehensive approach combining prevention, treatment and harm reduction, and taking into account the needs of people who use drugs and those of society as a whole.

These initiatives are developed on the basis of applied research in the humanities and social sciences, and their implementation and evaluation are based on scientifically validated strategies designed to answer one key question: do they work?

Understanding risk factors is crucial in modern drug prevention interventions, as it enables us to address the root causes of substance use and promote protective factors such as strong family bonds, engagement with school, and community support – Image by stokpic from pixabay, via Canva

Rather than raising awareness of the ‘dangers of drugs’, most initiatives today prefer to target risk factors and protective factors at the individual, family, community and environmental levels. These interventions are designed to be person-centred, while taking into account the many complex interactions between personal and environmental factors that may make certain populations more vulnerable to substance use or addiction. However, this has not always been the case. So what was prevention like before? Is prevention today so different from what it was in the past?

The origins of prevention: combating the ravages of alcohol

All forms of prevention stem from the 19th-century school of thought influenced by Pasteur’s work on the spread of disease: hygienism. This developed in a society plagued by diseases such as tuberculosis and cholera, which were widespread in most European countries, as well as in India, the United States and Canada.

With regard to substance use, it was alcohol that initially became the focus of efforts in Western countries. . In the countries concerned, the Industrial Revolution caused a profound change in drinking habits and exacerbated related problems. The advent of industrialization precipitated a period of exponential growth in the production, transportation and commercialization of alcohol. In urban areas, which experienced a significant increase in population following the rural exodus, millions of workers, reliant on their employers and lacking in social rights, found solace in alcohol, which had become readily available and inexpensive. Alcohol consumption increased significantly, as did the associated problems.

The temperance movement, a group of religious associations and leagues committed to combating the social ills of alcoholism, fought against the consumption of alcohol in the name of morality, good manners and the protection of the family unit. The influence of this movement grew until it reached its zenith in the early 20th century with the advent of alcohol prohibition laws, not only in the United States, but also in Canada, Finland and Russia – with the results we all know.

“The voluntary slave” – press illustration published in “La Fraternité” (France) for the Popular Anti-alcoholic league, author Adolphe Willette – circa 1875 – Adapted from screenshot from L’histoire par l’image

What about illegal drugs?

At the dawn of the 20th century, the concept of ‘illegal’ drugs had yet to be established. Europe and America had recently discovered a ‘remarkable substance’ – cocaine – lauded for its medicinal properties, touted as a panacea for all maladies. Initially imported in small quantities for medical research, its use grew rapidly, particularly within the medical community, and it was prescribed to treat a wide range of ailments, from toothache to morphine addiction. Sigmund Freud himself considered at the time cocaine to be a highly effective medicine for depression and stomach problems without causing addiction or side effects. With regard to cannabis and hashish, these were still available for purchase in all reputable pharmacies, while heroin, a registered trademark of the Bayer pharmaceutical company, was regarded as a sovereign remedy for… coughs.

It should be noted that the issue of substance addiction had not yet manifested itself in the context of affluent, colonizing nations. Elsewhere, the perspective was somewhat different: in a distant country – China – opium had already been wreaking havoc for several decades.

Introduced and marketed by Europeans, it had become a pervasive national scourge affecting millions of Chinese people. Opium  addiction is a prime example of the impact of colonialism on local societies: not only did it trigger two wars against Western powers concerned solely with their economic interests (profits from the opium trade), but it also had profound social and political consequences that are still felt today.

The Western countries’ ‘honeymoon’ with drugs was not to last. The problems they posed became apparent rapidly and, under the influence of American temperance leagues, they swiftly transitioned from being regarded as a universal remedy to being perceived as a threat to society and moral values. This marked the beginning of American policies predicated on drug control (or the war on drugs, depending on one’s perspective), which would shape global policies in this domain for over a century.

The demonization of ‘drugs’

The demonisation of drugs, the effects of which were felt from the beginning of the 20th century, is closely associated with a set of social, racial, political and economic dynamics that resulted in the stigmatization of both the substances themselves and the people who consumed them. As early as 1906, the United States initiated the legislative process, and the phenomenon grew until it culminated in a particularly restrictive and repressive international drug control policy – but that is another matter.

In the 1930s, the American government initiated a media offensive involving the use of racist stereotypes, sensationalist media, and political propaganda to portray cannabis as a dangerous substance that led to violence, insanity, and moral decay.

The process of demonizing drugs was gradual yet unstoppable. The discourse surrounding narcotics such as morphine, opium and heroin was initially shaped by their association with specific demographic groups, namely minorities, the economically disadvantaged, and migrants. This demonization continued over the following decades, fuelled by media sensationalism and public panic, particularly around the use of cocaine and cannabis – substances that were claimed to be the root cause of criminal behaviour and moral corruption.

The criminalization and stigmatization of substances and those who use them have had a profound impact. Not only have they perpetuated and reinforced racist prejudices against Afro-descendant, Latin American and other historically marginalized communities, but they have also completely distorted the approaches and prevention efforts implemented subsequently.

Early drug prevention initiatives

Before the 1960s, the ‘drug phenomenon’ was virtually non-existent in industrialised countries. Apart from a few opium enthusiasts, alcohol and tobacco reigned supreme in the field of substance addiction.

From the 1960s onwards, there was a rapid increase in the use of illegal drugs in the United States, particularly among the counterculture movement. The use of LSD and cannabis – and, to a lesser extent, amphetamines and heroin – spread and became a symbol of rebellion against authority, as part of a broader movement focused on social change.

Within the collective imagination, the 1960s are often regarded as the golden age of illegal drug use. This period was characterised by widespread use of cannabis, as well as the significant distribution of heroin among children in impoverished neighbourhoods. Notable figures such as Timothy Leary, a prominent Harvard professor, popularised the effects of LSD. However, an analysis of historical data reveals that the phenomenon was not as widespread as is commonly believed. Conversely, however, there was a marked increase in the perception of risk associated with drugs. For instance, in 1969, a mere 4% of American adults reported having used cannabis at least once. However, 48% of respondents indicated that drug use was a serious problem.

While many current prevention efforts have a solid theoretical basis and evidence of effectiveness, historic prevention strategies were often based on intuition and guesswork, with an emphasis on such scare tactics as the one depicted above (“Your brain on drugs” campaign, initially launched in 1987)

The notion of prevention as a concept was first developed in the early 1960s within the domain of mental health and behavioural disorders. In the context of drug policy, the first initiatives were echoing the pervasive fear of drugs that was prevalent in both America and Europe during that period. Logically, the primary initiatives were consistent with the propaganda campaigns initiated in previous decades with the objective of demonizing cannabis. The objective of these initial prevention initiatives was not to promote education, but rather to instil a sense of fear and intimidation.

Children and young people in the 1960s and 1970s were no more stupid than anyone else and just as observant. They quickly realised that the messages promoted by schools and families did not correspond to reality.

So simple, ‘Just Say No’.

In 1971, Richard Nixon declared drug abuse ‘public enemy number one’ and launched a widespread campaign against drug use, distribution and trafficking. This marked the beginning of a government policy that led to the incarceration of both traffickers and users. The policy would have far-reaching consequences for many countries, whilst in the United States it would have a disproportionately negative impact on the Black community.

The notion that one should ‘Just Say No’ to drugs is predicated on a rudimentary interpretation of the rational choice model, according to which people choose their behaviour in order to maximize rewards and minimize costs (negative consequences).

Nancy Reagan at a “Just Say No” rally at the White House in May 1986 – White House Photographic Collection, public domain

The D.A.R.E. programme: information is not enough

From 1983 onwards, this concept became central to the D.A.R.E. (Drug Abuse Resistance Education) programme. Initially implemented in Los Angeles, this school-based programme aimed to help young people understand that the harmful consequences of drug use far outweigh any perceived benefits. Young people can therefore avoid these consequences by refusing to take drugs.

The D.A.R.E programme’s model was based on three key elements: 1) drugs are bad; 2) when children understand how bad drugs are, they will avoid using them; and 3) the message is more effective when delivered by police officers, who are considered credible.

The programme was subsequently developed in the United Kingdom, and a similar model was adopted elsewhere in Europe during the same period — notably by associations of rehabilitated individuals — which replaced the credibility of police officers with that of former drug users ‘who could speak from experience’.

In response to findings on the ineffectiveness of the DARE programme, a new curriculum was developed (2009) with a stronger focus on interactive activities and decision-making skills, moving away from the traditional lecture-based approach by a police officer – AI-generated image, via Canva

Over the years, the programme has been the subject of extensive study. One study found that people who completed the programme had higher levels of drug use than those who did not. Another study found that teenagers enrolled in the D.A.R.E programme “were just as likely to use drugs as those who received no intervention”.

The impact of popular culture

The aim here is not to portray the D.A.R.E. programme or similar interventions solely in an unfavourable or ridiculous light. Even though it has lost its central position, the programme is still implemented in most US states, and according to its website, it has been developed in 29 countries since its creation. It is true that the programme has since been adapted to incorporate various aspects, such as resistance to peer pressure and the development of social skills.

However, these initiatives face a major difficulty from the outset. As we know, experimentation and risk-taking are part of normal adolescent development, which is why providing young people with detailed information about different substances is likely to arouse their interest in these drugs, especially if the information is not presented in an appropriate manner. Secondly, this type of strategy only has an impact on young people who are susceptible to alarmist messages because of their cognitive patterns, and is not effective for everyone else, as we now know.

Officers in the DARE programme would sometimes arrive in sports cars seized from drug traffickers to exemplify their message on drugs and crime (Crime does not pay) – A Pontiac Firebird in D.A.R.E. livery in Evesham Township, New Jersey – image: Jay Reed – Flickr, licence: CC BY-SA 2.0

Furthermore, when talking about drugs, one must also consider the influence of popular culture, which, without openly glorifying substance use, often portrays alcohol, tobacco, and other drugs in a favourable light, particularly at an age when young people are most receptive.

We now know that providing information about drugs is not enough to make for a good prevention policy. While education and awareness can always play an important role, they are not sufficient, nor even necessary, to prevent addiction.

Should we talk about drugs to prevent drug use?

According to Dr Rebecca Haines-Saah, who spoke at a webinar organised by Dianova last May, the most effective drug prevention strategies do not focus on drugs, but on much broader social issues, such as reducing poverty, combating discrimination and implementing targeted community programmes.

These approaches aim to create conditions that indirectly discourage drug use, particularly by strengthening social skills and improving people’s living conditions. For example, programmes focused on improving the school environment, teaching social skills or promoting healthy lifestyles can have a positive impact on reducing substance use without explicitly targeting drugs.

Similarly, family interventions that strengthen parent-child relationships and improve communication can also help prevent substance misuse by targeting underlying risk factors. These strategies highlight the importance of a holistic approach to prevention that goes far beyond direct drug education.

Prevention is a science

Preventing substance use – i.e. the use of all psychoactive substances regardless of their legal status –  involves helping people, particularly young people, to avoid using substances. If they have already used substances, the objective is to prevent them from developing substance use disorders (problematic use or dependence).

However, the overall objective is much broader, as highlighted by the UNODC in the second edition of the International Standards on Drug Use Prevention. It also involves ensuring that children and adolescents grow up healthy and safe, so they can fulfil their potential and become active and productive members of society.

Drug prevention is now grounded in research and evidence-based practices. This multi-disciplinary field has developed over the last forty years, aiming to improve public health by identifying risk and protective factors, assessing the efficacy of preventive interventions, and identifying optimal means for dissemination and diffusion –  AndreyPopov from Getty Images, via Canva

There is now a vast body of literature on substance use prevention. Its aim is to highlight effective and less effective strategies based on scientific evidence in order to guide decision-makers and practitioners in the field in their choices. Despite this, prevention activities are still sometimes poorly prepared and based primarily on beliefs or ideologies rather than scientific knowledge.

At Dianova, we believe that addiction prevention, particularly among young people, must take into account societal changes (new drugs, new patterns of use, changes in legislation, etc.) using scientifically validated strategies based on standards and methodological guidelines.

These strategies are based in particular on:

  • The acquisition of psychosocial skills (problem solving, decision-making, interpersonal skills, stress management, etc.),
  • Interventions aimed at developing parenting skills (e.g. communication skills, conflict management, setting boundaries, etc.),
  • Prevention strategies tailored to young people with vulnerability factors (e.g. those whose parents suffer from substance use disorders) and taking into account gender perspectives, abandoning androcentric strategies that obscure the situation of girls and LGBTQI+ communities.

In conclusion, we must bear in mind the mistakes of the past so as not to repeat them and, above all, understand that no prevention system is sufficient on its own. Whatever approach is chosen, effective prevention systems must be evidence-based and integrated into broader, balanced systems that focus on health promotion, the treatment of substance use disorders, risk and harm reduction, and countering drug trafficking.

Effective, science-based programmes that can make a real difference to people’s lives can only be developed by integrating all these elements.

Source: https://www.dianova.org/publications/a-brief-history-of-drug-prevention/

 

Report to Congressional Committees – July 2025  / GAO-25-107845 – United States GAO – (Government Accountability Office)

Highlights

A report to congressional committees.

For more information, contact: Triana McNeil – United States Government Accountability Office

What GAO Found

The 12 experts in a forum which GAO convened said that to develop effective media campaigns and evaluate media campaigns, whether on drug misuse prevention or other topics, campaigns need to consider the following: 

Graphical user interface, text, application AI-generated content may be incorrect.

·         Identify and understand intended audience. Once a campaign has identified who it wants to reach, it needs to understand the intended audience—including by identifying the underlying causes of the behavior the campaign wants to change. For example, experts noted that campaigns may decide to target the underlying reasons why people misuse drugs rather than developing campaigns to target specific drugs.

·         Create content, select messengers, and decide on delivery methods. Campaigns need to create content to deliver their messages, which need to be credible and relevant for the intended audience. Campaigns also need to select messengers to deliver their messages, such as community leaders. Additionally, campaigns need to decide how to deliver their messages. For example, campaigns may use print and social media, among other options.

·         Test messages. Campaigns need to test their messages with the intended audience to ensure that the messages are relevant and resonate with the intended audience. This testing can include using focus groups, interviews, or surveys, among other methods.

·         Define the intended outcome. Campaigns need to have a clear understanding of what they are trying to achieve. Then, evaluators can decide what data are needed to determine whether a campaign is meeting its goals.

·         Select qualified evaluators. Campaigns need independent evaluators who can speak to campaign managers about a campaign’s effectiveness using evidence from evaluations. Evaluators need expertise in research methods, evaluation, and other disciplines and need to understand the campaign substance.

·         Decide when and how to measure effectiveness. Campaigns need to decide if they will evaluate the campaign while it is ongoing or after the campaign has concluded. They also need to decide what they want to measure and what data collection methods they will use.

To access the full document:

  1. Click on the ‘Source’ link below.
  2. An image  – the front page of the full document will appear.
  3. Click on the image to open the full document.

Source: https://files.gao.gov/reports/GAO-25-107845/index.html?

New allegations have emerged about China’s role in the global fentanyl supply chain, highlighting the complex nature of international drug trafficking and the urgent need for comprehensive prevention strategies.

What We Know About Project Zero

According to Yuan Hongbing, a former Chinese academic now living in Australia, sources within Beijing’s political circles have described a coordinated effort called “Project Zero.” This alleged initiative represents one aspect of the broader China fentanyl crisis that has contributed to America’s ongoing opioid epidemic.

Yuan’s claims suggest that some Chinese officials view the current drug crisis through the lens of historical grievances, particularly the 19th-century Opium Wars. Whether accurate or not, these allegations underscore the complexity of the Chinese fentanyl trade and its impact on communities worldwide.

The Evolution of Supply Routes

The China fentanyl crisis has evolved significantly since 2019, when Beijing officially banned fentanyl production under international pressure. Rather than ending the problem, this led to a shift in tactics within the Chinese fentanyl trade.

Companies began focusing on precursor chemicals instead of finished products. These substances travel from manufacturing facilities to Mexico, where they’re processed into fentanyl before reaching American markets. This indirect approach complicates efforts to address the China fentanyl crisis at its source.

Impact on Communities

The human cost of the ongoing crisis is staggering. More than 107,000 Americans died from drug overdoses in 2023, with synthetic opioids like fentanyl being the primary cause. These deaths represent families torn apart and communities struggling with the consequences of widespread addiction.

The China fentanyl crisis affects people from all backgrounds. Parents lose children, children lose parents, and entire neighbourhoods face increased crime and social instability. Understanding these impacts is crucial for developing effective Chinese fentanyl trade prevention strategies.

Government Responses and Investigations

Congressional investigations have revealed concerning patterns in how some aspects of the Chinese fentanyl trade operate. The House Select Committee found evidence that certain companies receive government benefits for exporting precursor chemicals, raising questions about official oversight.

These findings suggest that addressing the China fentanyl crisis requires diplomatic engagement alongside enforcement measures. The complexity of international trade makes it challenging to distinguish between legitimate chemical exports and those intended for illicit use.

Economic Measures and Trade Relations

The current trade tensions between the US and China reflect broader concerns about the Chinese fentanyl trade. Recent tariffs include specific measures targeting fentanyl-related commerce, with most Chinese goods facing increased duties.

These economic responses acknowledge that the China fentanyl crisis extends beyond traditional criminal justice approaches. However, trade measures alone cannot solve the underlying issues that drive demand for these substances in affected communities.

International Cooperation Challenges

Addressing the Chinese fentanyl trade requires unprecedented international cooperation. Different legal systems, varying enforcement capabilities, and complex diplomatic relationships all complicate efforts to tackle the China fentanyl crisis effectively.

Success depends on finding common ground between nations with different perspectives on regulation, enforcement, and prevention. This includes sharing intelligence, coordinating investigations, and developing consistent approaches to precursor chemical controls.

The Role of Prevention

Prevention remains the most effective long-term response to the China fentanyl crisis. Community-based programmes that educate young people about the dangers of substance use can reduce demand for these deadly drugs.

Effective prevention strategies address the root causes that make individuals vulnerable to addiction. This includes mental health support, educational opportunities, and strong community connections that provide alternatives to substance use.

When communities invest in prevention, they create protective factors that help people resist the appeal of drugs, regardless of their source. The Chinese fentanyl trade thrives where demand exists, making prevention efforts crucial for breaking this cycle.

Treatment and Recovery

For those already affected by the China fentanyl crisis, accessible treatment services provide hope for recovery. Evidence-based approaches that combine medical treatment with psychological support offer the best outcomes for people struggling with addiction.

Recovery programmes that involve families and communities tend to be more successful than those focusing solely on individual treatment. This holistic approach recognises that addiction affects entire social networks, not just individual users.

The Path to Prevention and Recovery

The allegations about Chinese involvement in fentanyl trafficking highlight the need for sustained international cooperation on drug prevention. Whether through diplomatic channels, trade measures, or community-based initiatives, addressing this crisis requires coordinated action.

Prevention must remain at the centre of any effective response to the China fentanyl crisis. By reducing demand through education and community support, we can address the root causes that make these supply chains profitable in the first place.

The Chinese fentanyl trade represents a complex challenge that requires nuanced solutions. Success will depend on combining international cooperation with strong local prevention efforts that protect vulnerable individuals and strengthen community resilience.

Only through sustained commitment to prevention, treatment, and community support can we hope to reduce the devastating impact of the China fentanyl crisis on families and communities worldwide.

Source: https://nobrainer.org.au/index.php/resources/wheelbarrows/1469-china-fentanyl-crisis-a-global-challenge-requiring-prevention?

by Vivek Ramaswamy <news@editor.thepostmillennial.com>  01 July 2025 14:34

THE KIDS WILL BE OK

You will never guess what’s happening with young people.  ‌ Believe it or not, the younger generation is finally rejecting woke and radical leftism. You saw this during Trump’s election – a major shift in the 18-29 year old voters.‌ ‌ And the media hates it! ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Here’s a major reason why this is happening … an organization called Young Americans for Liberty (YAL) is identifying, recruiting, and training college students to Make Liberty Win. YAL is the most active and effective pro-liberty youth organization advancing liberty on campus. …..

YAL is doing this, first and foremost, by reaching students where they’re at. By focusing on the issues important to twenty-year-olds – affordable groceries and gas, healthcare, and guns, YAL is able to show young people that socialism is not the answer to all of their life’s problems.

Here are a few of the articles, supporting  this initiative, published in other publications:

  • “America’s Youngest Voters Turn Right” – Axios;
  • “The Not-So-Woke Generation Z” – The Atlantic;
  • “Are Zoomers Shifting Right?” – Newsweek; and
  • “Analysis: Young and Non-White Voters Have Shifted Right Since 2020” – Washington Post.

Below is a step-by-step layout showing how Young Americans for Liberty is advancing the ideas of freedom with college students.
 

STEP 1: Expand the number of YAL chapters across the country to over 500 nationwide. America’s college campuses are covered with YAL chapters actively recruiting and educating hundreds of thousands of students.
 

STEP 2: Recruit 10,000 NEW YAL members and collect more than 150,000 student sign-ups. YAL is building a massive network and a strong foundation to reach the next generation for years to come.
 

STEP 3: Train an ELITE group of top 1,7000 student leaders on how to WIN ON PRINCIPLE. YAL’s top student leaders receive exclusive training on the strategies and tactics to win and advance the ideas of liberty.

STEP 4: Mobilize YAL-trained activists who have knocked on more than 6,000,000 doors to promote liberty causes and candidates. It’s called OPERATION WIN AT THE DOOR, and through it, YAL-trained students have knocked doors to help nearly 400 pro-liberty legislators win crucial races and push for important pro-liberty legislation.
 

STEP 5: Fight tyrannical campus policies and college administrators through YAL’s Student Rights Campaign. YAL chapters and members have made major policy changes on free speech, self-defense, and defunding woke campus programs, which now impact more than 3,100,000 students every year.

Young Americans for Liberty, 3267 Bee Cave Rd, Ste 107-65, Austin, TX 78746, United States

Source:  Post Millennial, 2515 Waukegan Road #1ABC, Deerfield, IL 60015

Filed under: Strategy and Policy,USA,Youth :
Some hopeful news has come to light in the latest Drug Enforcement Administration (DEA) Annual Report: overdose deaths dropped more than 20% nationwide in 2024, which is the largest yearly decrease in four decades of tracking. Although this decrease in overdose deaths is good news, it does not mean the crisis is over. Changes in drug mixtures, independent regional shifts in overdose patterns, and the alarming rise in new chemical contaminants—many of which users don’t even know they’re taking—makes this ever-evolving issue complex and increasingly more dangerous than ever before.

 

The DEA found that 1 in 8 samples of methamphetamine now contains fentanyl, and 1 in 4 samples of cocaine samples are similarly contaminated. And while deaths from fentanyl may be decreasing, fentanyl is increasingly being mixed into other drugs, often with deadly result.

In a regional assessment of fentanyl-related deaths, stimulants such as cocaine and methamphetamine were found to be contaminated with fentanyl and linked to 1 out of every 2 drug-related deaths in the west and 1 out of every 3 drug-related deaths in the east. Contaminated drug mixtures are especially dangerous given that naloxone, one of the key measures in reducing opioid overdose deaths, is ineffective against non-opioid drugs such as stimulants.

 

Among the surprising findings was that between 2018 and 2022, fentanyl-only overdose among 15-24 year olds increased approximately 168%. This age group, which is one that generally does not seek fentanyl, are suspected to be unknowingly consuming drugs laced with it. The low production cost of fentanyl continues to fuel the shift between already dangerous plant-based drugs to lab-made substances. The emergence of additives that cause prolonged sedation such as xylazine and medetomidine increase the dangers associated with the consumption of these drugs as some these mixtures may also render naloxone ineffective.

 

Despite the drop in overall overdose deaths the U.S. still has the highest drug overdose rate in the world, with 324 deaths per million people. Most states are showing promising progress with decreases in drug-related deaths. However, Nevada is an exception, experiencing an increase largely driven by methamphetamines, which have now surpassed fentanyl as the leading cause of drug-related deaths in the state.

 

Although overall trends seem to show a positive promising future, the drug supply is evolving faster than available tools can manage. And overdose risks are no longer about misuse, but also about unknowing exposure to potent synthetic chemicals hidden in recognizable drugs.

 

 

Source:  Drug Free America Foundation | 333 3rd Ave N Suite 200 | St. Petersburg, FL 33701 US

 

Every year the United Nations Office on Drugs and Crimes releases the World Drug Report (WDR) on World Drug Day, which is observed annually on June 26th. The WDR provides updates on international drug markets, policy changes across the world, and summarizes gathered data on ongoing issues caused by drugs on all fronts.

This year’s report calls for communities around the world to break the cycle and #StopOrganizedCrime, stressing the intricacy and ever-expanding reach of organized crime networks on a global scale currently exacerbated by increased global instability. 

Among this year’s highlights, the World Drug Report finds a 28% increase in people who use drugs over the past 10 years, with marijuana the top used substance with 244 million users, followed by opioids, amphetamines, cocaine, and ecstasy.

The report also highlights a 13% increase in people suffering from drug use disorders over the past 10 years and the disproportionate imbalance among men and women with substance use disorders (SUD) who receive treatment. While 1 in 7 men with a substance use disorder receive treatment, only 1 in 18 women with SUD receive treatment.

But the most sobering reality is that youth continue to show a steady rise in drug use over the past decade. Vulnerable populations are bearing the brunt of illegal exploits and are falling prey to the cycle of poverty and crime created by underfunded systems and increased criminal activity.

Stimulant-related criminal activity is growing at an alarming rate. Between 2013-2023, global cocaine production rose 34%, global cocaine seizures rose 68%, and the number of people who use cocaine jumped from 17 million to 25 million. The steady expansion of cocaine use and rise in production continues to break records year after year. Additionally, the synthetic drug market led by methamphetamines and captagon continues to grow with drug and human trafficking feeding criminal networks that are constantly adapting to new intelligence and technological advances. The influence of this global drug crisis is reflected not only on the financial costs to communities, but on health systems, the environment, public safety, and above all, the loss of life.

Now more than ever, prevention plays a vital role in breaking the harmful cycles created by substance use. While local organizations witness the impact of drugs firsthand in their communities, and governments work to address supply and demand on a global scale, civil society is uniquely positioned to listen, respond, and offer immediate support to local leaders and at-risk populations.

By collaborating with organizations and building a network of support, we can empower individuals with evidence-based resources that strengthen protective factors, promote education, and foster long-term resilience.

Drug Free America Foundation leads the Global Task Force, uniting international non-governmental organizations with this shared mission. If you are interested in joining, please reach out to clincoln@dfaf.org .

If you would like to read the full World Drug Report click here 

Source:  Drug Free America Foundation | 333 3rd Ave N Suite 200 | Saint Petersburg, FL 33701 US

Key points

  • Substance use prevention is not just focused on the absence of a disease or illness but on promoting wellness.
  • Funding cuts from DOJ for substance use and treatment services may have long-term consequences.
  • These cuts represent the latest cycle of punitive sentiments towards substances use.

On April 22, the Department of Justice (DOJ) announced the termination of 365 awards that “no longer effectuate Department priorities.” Among these cuts were $88 million in Office of Justice Programs (OJP) funded programs administering substance use and mental health services. During Preisdent Trump’s first term, we witnessed a shift away from behavioral health models toward scare tactics and increased law enforcement activities — strategies known to be ineffective at preventing substance use. This term appears to be following that same trajectory.

America has a long history of reactively and emotionally addressing substance use in ways inconsistent with research and best practices. Large swings in political views and funding are not new and have detrimental effects on prevention efforts and communities. This latest rollback represents a reversion back to failed, punitive models, which threatens to unravel decades of progress in promoting community health and wellness.

Substance Use Prevention

Today’s substance use prevention activities are not the mass media scare campaigns seen during the 1960s to the 1990s or as simple as “Just Say No.” Substance use prevention takes a public health approach to promoting wellness and preventing substance use problems.

Unlike early iterations of “prevention,” the ultimate goal of prevention activities today is to promote wellness. Promoting wellness is not the same as advocating for the absence of a disease or illness but the presence of purpose in life, involvement in satisfying work and play, having joyful relationships, a healthy body and living environment, as well as general happiness. The Substance Abuse and Mental Health Services Administration (SAMHSA), drawing on Swarbrick’s wellness approach, describes wellness as having eight different dimensions – emotional, spiritual, intellectual, physical, environmental, financial, occupational, and social.

Effective prevention programs work across these dimensions to reduce factors that put people at risk of developing behavioral health disorders (i.e., risk factors) as well as promote or strengthen factors that protect people from these disorders (i.e., protective factors).

The Cycle of Prevention Activities

The way we have responded to substance use has always been reactionary and punitive. Responses to substance use in the U.S. has stretched back over a century and followed a repeating cycle of panic, punishment, and progress. A new drug “hits the streets,” a news article highlights the death of a young, innocent victim, or a new political ringleader will enter the scene spouting “tough on crime” rhetoric that causes a moral panic among the masses and calls for increased punishment. Those sentiments take hold for several years and lead to prison overcrowding and an increase in arrest rates. Eventually, scientific advancements push responses to substance use back into the behavioral health realm. Then, a political campaign or story regresses the U.S. back to failed models of addressing substance use with punishment and the cycle repeats.

The 1950s/1960s are generally seen as the beginning of the modern era of prevention — an era dominated by fear-based approaches. School talks aimed at “scaring kids straight” and media campaigns and movies painted exaggerated horror stories about drug use. But scare-based tactics never work, particularly when youth can see that the lessons don’t reflect their lived experience. By the 1970s, the “War on Drugs” had been launched, and President Nixon had called drugs America’s “public enemy number one” and ushered in a wave of punishment over support. One of the most popular mantras of prevention originated in the 1980s with Nancy Reagan’s famous phrase: ‘Just Say No.’ It was catchy, simple, and widespread, but ultimately ineffective.

In the 1990s, science began to shape prevention and we saw large drops in youth substance use rates ever since. Researchers began to examine risk and protective factors associated with substance use. These studies led to a more structured approach to prevention. New, evidence-based school curricula focused on building life skills, resilience, and relationships were implemented. Community coalitions like the Communities That Care model gained traction. This progress continued in the early 2000s, when prevention finally got a seat at the table in public health. Prevention efforts became evidence-based and multi-layered. Programs began to see substance use as due to a complex interaction between systems and started addressing the risk at the family-, peer-, school-, and individual-level, such as the Seattle Social Development Project.

But this progress is often undermined by political agendas.

The punitive spirit of the War on Drugs remains deeply embedded in U.S. policy. The first Trump administration marked a clear pivot away from behavioral health and back toward criminal justice responses. Law enforcement became the answer while programs focused on research and wellness were deprioritized. Youth substance use trends began to stabilize despite the steady decline they had been on since the 1980s, marking an early sign that prevention was losing its momentum. The Biden-Harris administration brought in a new wave of the War on Drugs by naming a specific adulterated substance, fentanyl combined with xylazine, as an “emerging threat to the United States,” a term traditionally held for matters of homeland security.

Why This Matters Now

This new Trump administration brings new challenges and likely worse consequences as we witness an unprecedented time of widespread cuts to federal funding. Many communities rely heavily on these programs to help their fellow residents promote wellness in their area. Without these programs, improvements in trends in substance use will likely plateau, then potentially worsen. The challenge is that the consequences of cutting prevention are long-term, not immediate. As a result, many will turn to this time period in the next year to point out that there was no visible crisis or dramatic increase in substance use but that is based on a deep misunderstanding in evaluation research. The kids that would have relied on these programs will reach adulthood in the next few years which will be when we see the effects of not having these programs. People who relied on federally funded programs for treatment and support will experience worsening symptoms and rates of fatal overdoses will rise. Our schools will likely witness lower rates of attendance and a higher number of students dropping out or failing. Issues of overcrowding in jails and prisons will continue to worsen as increases in law enforcement activity will lead to greater arrests.

The defunding of mental health and substance use programming is a mistake. When prevention works, it’s invisible — no one sees the overdoses that didn’t happen, hears the fights that were avoided, or reads headlines about the crisis that never occurred. The invisibility of its effects does not mean it is not important.

Mobilizing the Community

We are at risk of repeating history by cutting prevention and returning to failed punitive models. Communities must lead where the federal government is failing. The momentum for prevention has always lain in the power of the community. The earliest substance use prevention movements started with everyday people who cared. Mothers Against Drunk Drivers (MADD) and other grassroots organizations started taking an active role in prevention in the 1980s, and ever since we have seen more communities taking the reins when it comes to promoting wellness in their area. Prevention is not an activity reserved solely for those in power; it is the duty and responsibility of every individual. Prevention is more than a policy or program; it is a promise to keep showing up for each other. If you are not sure where to start, start by telling your story and making space for others to lead. Prevention is strongest when it is shared.

Source:  https://www.psychologytoday.com/us/blog/the-nature-of-substance-use/202505/defunding-prevention-a-setback-for-science-and-public

 

Los Angeles — Inside a bright new building in the heart of Skid Row, homeless people hung out in a canopy-covered courtyard — some waiting to take a shower, do laundry, or get medication for addiction treatment. Others relaxed on shaded grass and charged their phones as an intake line for housing grew more crowded.

The new Skid Row Care Campus offers homeless people health care and a place to rest, charge their phones, grab some

food, or even get connected with housing.Angela Hart / KFF Health News

 

The Skid Row Care Campus officially opened this spring with ample offerings for people living on the streets of this historically downtrodden neighborhood. Pop-up fruit stands and tent encampments lined the sidewalks, as well as dealers peddling meth and fentanyl in open-air drug markets. Some people, sick or strung out, were passed out on sidewalks as pedestrians strolled by on a recent afternoon.

For those working toward sobriety, clinicians are on site to offer mental health and addiction treatment. Skid Row’s first methadone clinic is set to open here this year. For those not ready to quit drugs or alcohol, the campus provides clean syringes to more safely shoot up, glass pipes for smoking drugs, naloxone to prevent overdoses, and drug test strips to detect fentanyl contamination, among other supplies.

As many Americans have grown increasingly intolerant of street homelessness, cities and states have returned to tough-on-crime approaches that penalize people for living outside and for substance use disorders. But the Skid Row facility shows Los Angeles County leaders’ embrace of the principle of harm reduction, a range of more lenient strategies that can include helping people more safely use drugs, as they contend with a homeless population estimated around 75,000 — among the largest of any county in the nation. Evidence shows the approach can help individuals enter treatment, gain sobriety, and end their homelessness, while addiction experts and county health officials note it has the added benefit of improving public health.

“We get a really bad rap for this, but this is the safest way to use drugs,” said Darren Willett, director of the Center for Harm Reduction on the new Skid Row Care Campus. “It’s an overdose prevention strategy, and it prevents the spread of infectious disease.”

Despite a decline in overdose deaths, drug and alcohol use continues to be the leading cause of death among homeless people in the county. Living on the streets or in sordid encampments, homeless people saddle the health care system with high costs from uncompensated care, emergency room trips, inpatient hospitalizations, and, for many of them, their deaths. Harm reduction, its advocates say, allows homeless people the opportunity to obtain jobs, taxpayer-subsidized housing, health care, and other social services without being forced to give up drugs. Yet it’s hotly debated.

Politicians around the country, including Gov. Gavin Newsom in California, are reluctant to adopt harm reduction techniques, such as needle exchanges or supervised places to use drugs, in part because they can be seen by the public as condoning illicit behavior. Although Democrats are more supportive than Republicans, a national poll this year found lukewarm support across the political spectrum for such interventions.

Los Angeles is defying President Trump’s agenda as he advocates for forced mental health and addiction treatment for homeless people — and locking up those who refuse. The city has also been the scene of large protests against Mr. Trump’s immigration crackdown, which the president has fought by deploying National Guard troops and Marines.

Mr. Trump’s most detailed remarks on homelessness and substance use disorder came during his campaign, when he attacked people who use drugs as criminals and said that homeless people “have no right to turn every park and sidewalk into a place for them to squat and do drugs.” Health and Human Services Secretary Robert F. Kennedy Jr. reinforced Mr. Trump’s focus on treatment.

“Secretary Kennedy stands with President Trump in prioritizing recovery-focused solutions to address addiction and homelessness,” said agency spokesperson Vianca Rodriguez Feliciano. “HHS remains focused on helping individuals recover, communities heal, and help make our cities clean, safe, and healthy once again.”

A comprehensive report led by Margot Kushel, a professor of medicine at the University of California-San Francisco, this year found that nearly half of California’s homeless population had a complex behavioral health need, defined as regular drug use, heavy drinking, hallucinations, or a recent psychiatric hospitalization.

The chaos of living outside, she said — marked by violence, sexual assault, sleeplessness, and lack of housing and health care — can make it nearly impossible to get sober.

Skid Row Care Campus

The new care campus is funded by about $26 million a year in local, state, and federal homelessness and health care money, and initial construction was completed by a Skid Row landlord, Matt Lee, who made site improvements on his own, according to Anna Gorman, chief operating officer for community programs at the Los Angeles County Department of Health Services. Operators say the campus should be able to withstand potential federal spending cuts because it is funded through a variety of sources.

Glass front doors lead to an atrium inside the yellow-and-orange complex. It was designed with input from homeless people, who advised the county not just on the layout but also on the services offered on-site. There are 22 recovery beds and 48 additional beds for mostly older homeless people, arts and wellness programs, a food pantry, and pet care. Even bunnies and snakes are allowed.

John Wright, 65, who goes by the nickname Slim, mingled with homeless visitors one afternoon in May, asking them what they needed to be safe and comfortable.

“Everyone thinks we’re criminals, like we’re out robbing everyone, but we aren’t,” said Wright, who is employed as a harm reduction specialist on the campus and is trying, at his own pace, to stop using fentanyl. “I’m homeless and I’m a drug addict, but I’m on methadone now so I’m working on it,” he said.

Nearby on Skid Row, Anthony Willis rested in his wheelchair while taking a toke from a crack pipe. He’d just learned about the new care campus, he said, explaining that he was homeless for roughly 20 years before getting into a taxpayer-subsidized apartment on Skid Row. He spends most of his days and nights on the streets, using drugs and alcohol.

The drugs, he said, help him stay awake so he can provide companionship and sometimes physical protection for homeless friends who don’t have housing. “It’s tough sometimes living down here; it’s pretty much why I keep relapsing,” said Willis, who at age 62 has asthma and arthritic knees. “But it’s also my community.”

Willis said the care campus could be a place to help him kick drugs, but he wasn’t sure he was ready.

Research shows harm reduction helps prevent death and can build long-term recovery for people who use substances, said Brian Hurley, an addiction psychiatrist and the medical director for the Bureau of Substance Abuse Prevention and Control at the Los Angeles County Department of Public Health. The techniques allow health care providers and social service workers to meet people when they’re ready to stop using drugs or enter treatment.

“Recovery is a learning activity, and the reality is relapse is part of recovery,” he said. “People go back and forth and sometimes get triggered or haven’t figured out how to cope with a stressor.”

Swaying public opinion

Under harm reduction principles, officials acknowledge that people will use drugs. Funded by taxpayers, the government provides services to use safely, rather than forcing people to quit or requiring abstinence in exchange for government-subsidized housing and treatment programs.

Los Angeles County is spending hundreds of millions to combat homelessness, while also launching a multiyear “By LA for LA” campaign to build public support, fight stigma, and encourage people to use services and seek treatment. Officials have hired a nonprofit, Vital Strategies, to conduct the campaign including social media advertising and billboards to promote the expansion of both treatment and harm reduction services for people who use drugs.

The organization led a national harm reduction campaign and is working on overdose prevention and public health campaigns in seven states using roughly $70 million donated by Michael Bloomberg, the former mayor of New York.

“We don’t believe people should die just because they use drugs, so we’re going to provide support any way that we can,” said Shoshanna Scholar, director of harm reduction at the Los Angeles County Department of Health Services. “Eventually, some people may come in for treatment but what we really want is to prevent overdose and save lives.”

Los Angeles also finds itself at odds with California’s Democratic governor. Newsom has spearheaded stricter laws targeting homelessness and addiction and has backed treatment requirements for people with mental illness or who use drugs. Last year, California voters approved Proposition 36, which allows felony charges for some drug crimes, requires courts to warn people they could be charged with murder for selling or providing illegal drugs that kill someone, and makes it easier to order treatment for people who use drugs.

Even San Francisco approved a measure last year that requires welfare recipients to participate in treatment to continue receiving cash aid. Mayor Daniel Lurie recently ordered city officials to stop handing out free drug supplies, including pipes and foil, and instead to require participation in drug treatment to receive services. Lurie signed a recovery-first ordinance, which prioritizes “long-term remission” from substance use, and the city is also expanding policing while funding new sober-living sites and treatment centers for people recovering from addiction.

“Harm encouragement”

State Sen. Roger Niello, a Republican who represents conservative suburbs outside Sacramento, says the state needs to improve the lives of homeless people through stricter drug policies. He argues that providing drug supplies or offering housing without a mandate to enter treatment enables homeless people to remain on the streets.

Proposition 36, he said, needs to be implemented forcefully, and homeless people should be required to enter treatment in exchange for housing.

“I think of it as tough love,” Niello said. “What Los Angeles is doing, I would call it harm encouragement. They’re encouraging harm by continuing to feed a habit that is, quite frankly, killing people.”

Keith Humphreys, who worked in the George W. Bush and Barack Obama administrations and pioneered harm reduction practices across the nation, said that communities should find a balance between leniency and law enforcement.

“Parents need to be able to walk their kids to the park without being traumatized. You should be able to own a business without being robbed,” he said. “Harm reduction and treatment both have a place, and we also need prevention and a focus on public safety.”

Just outside the Skid Row Care Campus, Cindy Ashley organized her belongings in a cart after recently leaving a local hospital ER for a deep skin infection on her hand and arm caused by shooting heroin. She also regularly smokes crack, she said.

She was frantically searching for a home so she could heal from two surgeries for the infection. She learned about the new care campus and rushed over to get her name on the waiting list for housing.

“I’m not going to make it out here,” she said, in tears.

Source:  https://www.cbsnews.com/news/los-angeles-harm-reduction-drugs-homelessness/

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF — the independent source for health policy research, polling, and journalism.

 

by Robyn Oster – Associate Director, Health Law and Policy – July 2025

Reminder: The U.S. Preventive Services Task Force (USPSTF), an expert panel, evaluates preventive services and recommends which should be provided at no cost.

  • Why it’s important: Services currently required to be covered at no cost include certain mental health screenings, drug/alcohol screenings, PrEP for HIV, etc.
  • A group of conservative Christian employers in Texas led a lawsuit challenging the requirement. They argued that having the independent panel determine national health coverage violated the appointments clause of the Constitution and that covering PrEP violated religious freedom (though the Supreme Court only weighed in on the appointments clause argument).

The details:

  • The employers argued that USPSTF members were not appointed as either of two types of executive branch officers that the Constitution allows to make certain national policy decisions. They argued that the task force recommendations requiring them to cover certain preventive services in their employer-sponsored health plans were unconstitutional because task force members are not confirmed by the Senate.
  • The government defended the task force, arguing that it is constitutional because HHS officials appoint USPSTF members, and the HHS secretary can remove members at will and veto recommendations.
  • The Supreme Court agreed with the government and affirmed that the HHS secretary has these powers over USPSTF and its recommendations.

The bigger context:

  • The decision is a win for health advocates, who wanted to maintain the no-cost coverage requirement for preventive services. Providing preventive services at no cost is key to increasing access to and receipt of important screenings and other preventive services. Decreasing access to such services would lead to worse health outcomes.
  • But: The ruling could challenge USPSTF’s independence and credibility. It cements a strong role for the HHS secretary in overseeing the USPSTF, including removing members and modifying its rulings. This paves the way for HHS Secretary Kennedy to reject recommendations he disagrees with, allowing insurers to charge for those services or avoid covering them in some cases. It also opens the door for Kennedy to remove all the task force members and appoint new people, and a new task force could reject previous recommendations.

Source:  https://drugfree.org/drug-and-alcohol-news/supreme-court-upholds-aca-preventive-care/

The Association of Community Pharmacists of Nigeria (ACPN)

has advocated  urgent, coordinated, and sustained actions

to combat drug abuse which has constituted

a major public health menace.

by Onyebuchi Ezigbo in Abuja

In his message to mark the International Day Against Drug, the National Chairman of ACPN,  Ezeh Ambrose Igwekamma, said that focus should now be home prevention, education, early intervention, and rehabilitation.

“As the National Chairman of ACPN, I join millions around the world to reaffirm our commitment to the fight against drug abuse and to call for urgent, coordinated, and sustained actions to combat this public health menace in our dear country,” he said.

 Igwekamma said the theme for this year’s celebration, “The Evidence is Clear: Invest in Prevention,” resonates deeply with our vision at the ACPN.

“It reminds us that we must shift our focus from reaction to prevention. As community pharmacists—trusted, accessible healthcare providers on the frontlines—we witness firsthand the silent crisis of substance abuse in our communities, especially among our youth.” 

He said ACPN for more than  a decade has demonstrated a concerns on massive awareness creation through  the National Anti-Drug abuse competition among students in secondary school nationwide.

According to him, the essence of the annual competition is for prevention and also to dis abused the minds of younger generations against the consequences of drug abuse which Align with the same with the  UNODC Strategic plan for substance Abuse 

He added: “Every tablet sold without prescription, every codeine cough syrup diverted, and every hard drug traded illegally is not just a crime—it is a threat to our collective future. 

“Drug abuse fuels mental health disorders, crime, school dropout, family breakdown, and premature deaths. It cripples dreams and sabotages national development”.

The ACPN president  called on all stakeholders—government, civil society, security agencies, religious and traditional leaders, parents, and educators—to intensify their roles in prevention, education, early intervention, and rehabilitation.

Source:  https://www.thisdaylive.com/2025/06/27/drug-abuse-attention-must-now-shift-to-prevention-says-acpn/

by Sihyun Baek,

Grade 11, (16-17 years old)

Chadwick International School

06.29.2025

 

[AI Generated, Addiction. Photo Credit to Pixabay]

South Korea is grappling with a mounting crisis as incidents of teenage drug use increase exponentially, raising serious concerns about youth safety and failed public education systems.

The latest incident, involving two middle schoolers caught using marijuana in a neighborhood playground in Seoul on April 25, has once again brought the issue to the forefront for concerned parents, teachers, and lawmakers alike. 

The students were seen smoking liquid cannabis in broad daylight, prompting local residents to notify the police. 

Authorities are currently looking into how the teens obtained the drugs.

Nationally, the number of juvenile drug offenders, aged 18 and younger, rose to 450 in 2021, marking a 43.8% increase from the previous year and nearly quadrupling since 2018, according to the Supreme Prosecutors’ Office. 

In Seoul alone, teenage drug offenders surged nearly fivefold in just one year, from 48 in 2022 to 235 in 2023.

South Korea, known for its stringent drug laws and historically low rates of domestic usage, now finds itself fighting against a growing number of youth turning to drugs through online platforms and encrypted messaging services like Telegram. 

The rise of drug transactions using anonymous cryptocurrency transactions such as  Bitcoin has dramatically lowered the barriers to accessing such substances online. 

In one case during the summer of 2022, for instance, a drug cartel run entirely online by an 18-year-old using encrypted apps to distribute methamphetamine and MDMA was exposed by police officers. 

Similarly, in November of 2021, a drug-trading chat room was discovered on Telegram.

Prosecutors revealed that all 180 members of the chat room were members of a criminal drug organization, most of whom were teenagers.  

But marijuana and party drugs aren’t the only substances of concern. 

Illegally obtained prescription psychotropic medications are emerging as the country’s primary gateway drugs. 

An increasing number of teenagers have been caught distributing fentanyl patches and pills like Dietamin, an appetite suppressant.

The pill, however, is also a dangerous psychotropic drug derived from amphetamines that produces hallucinations and has addictive properties.

These prescription drugs, often perceived as “safe” or “medically approved,” are creating a dangerous normalization of drug use among teens and increasing the risk of long-term addiction and overdose.

From 2019 to 2021, prescription psychotropics accounted for 55.4% of youth drug cases, followed by cocaine and heroin at 23.8%, and marijuana at 20.8%. 

In one major investigation in June of 2023, 100 teenagers in South Gyeongsang Province were arrested for selling and abusing Dietamin tablets obtained online.

Experts point to peer pressure and stress as the key triggers, particularly within Telegram chat rooms. 

Pop culture also plays a significant role; for example, fentanyl was commonly used by hip-hop rappers in 2019 and has since grown in popularity among teenagers.

To counter this growing issue, authorities have begun intense cyber investigations. 

In 2023 alone, more than 1,000 online crackdowns led to the shutdown of 78 drug-dealing accounts on platforms like Telegram and Instagram. 

Yet, the increasingly sophisticated methods of drug distribution pose serious challenges for law enforcement.

Dealers frequently change their online handles, communicate in code using emojis, and utilize “dead drop” methods, such as hiding drugs in public spaces for buyers to retrieve using GPS coordinates, making it difficult for someone to trace their tracks. 

Understandably, the consequences of this rise in drug use among teenagers are devastating. 

 Drug abuse has been directly linked to an increase in youth suicide attempts. 

Between 2019 to mid-2023, approximately 46.4% of teen suicide attempts resulting in hospitalization were associated with drug use, according to the National Medical Center. 

In 2021 alone, 1,678 minors were treated for drug abuse, a 41.4% jump from the previous year.

To combat this issue, many suggest implementing strengthened education systems on drugs by collaborating with related institutions.

Likewise, while some lawmakers have recently proposed bills to mandate such education programs, experts say the movement lacks urgency and public support and is failing to garner much attention, with the country having yet to integrate drug prevention into its national school curriculum.

For instance, in May of 2024, Government Representative Lee Tae-kyu proposed a bill to mandate drug education in schools, requiring them to implement age-specific drug education programs in collaboration with public health agencies. 

However, as of now, the bill remains stalled in committee.

Comparatively, in the United States, the implementation of Drug Abuse Resistance Education (DARE) programs nationwide began as early as the 1980s, laying the foundation for more modern prevention strategies. 

Simultaneously, South Korea continues to face a lack of infrastructure for rehabilitation sites, as they still remain largely underdeveloped. 

Experts estimate that around 40% of Korean drug offenders return to prison within three years of their release. 

Such a high rate is often linked to the stigma they face in society, with many struggling to find employment, being rejected by hospitals, and being generally excluded from mainstream social life.

Likewise, the number of rehabilitation facilities for minors is limited.  

KAADA, one of the few rehabilitation centers for teen users, receives about 1,000 patients per year, only 10% of whom are under 19. 

Experts note that this is not reflective of actual use rates, but rather the result of underreporting and such social stigma that keep teens and their families silent.

Data gaps also hinder progress. 

Because many teen users are released as first-time offenders, their cases often fail to reach prosecutors, resulting in underreported figures. 

This makes it harder for lawmakers to assess the full scale of the crisis or design policies that address it adequately.

Parents have taken to online forums to express their fears, demanding school assemblies, national awareness campaigns, and stricter regulations on medical prescriptions.

In an interview with Ms. Cha, a concerned parent, commented, “It worries me even more because I don’t have a way of knowing what my child does online, especially as he gets older. You have to respect their autonomy, but at the same time, they could be accessing websites and chat rooms they shouldn’t be in.” 

Another parent, Mr. Kim, stated, “We need more education programs about drug prevention at school. Our children know that drugs are bad, but they don’t fully understand the long-term consequences or how easily peer pressure can lead them down the wrong path.”

Source:  http://www.heraldinsight.co.kr/news/articleView.html?idxno=5498

From the Editor, thepostmillennial.com 01 July 2025 14:34

(original text  draft by Vivek Ramaswamy)

Something BIG is happening on college campuses across the United States.

Believe it or not, the younger generation is finally rejecting woke and radical leftism. You saw this during Trump’s election – a major shift in the 18-29 year old voters.

And the media hates it!

  • “America’s Youngest Voters Turn Right” – Axios;
  • “The Not-So-Woke Generation Z” – The Atlantic;
  • “Are Zoomers Shifting Right?” – Newsweek; and
  • “Analysis: Young and Non-White Voters Have Shifted Right Since 2020” – Washington Post.

Here’s a major reason why this is happening.

An organization called Young Americans for Liberty (YAL) is identifying, recruiting, and training college students to Make Liberty Win. YAL is the most active and effective pro-liberty youth organization advancing liberty on campus.

YAL is doing this, first and foremost, by reaching students where they’re at. By focusing on the issues important to twenty-year-olds – affordable groceries and gas, healthcare, and guns, YAL is able to show young people that socialism is not the answer to all of their life’s problems.

Below I lay out step-by-step how Young Americans for Liberty is advancing the ideas of freedom with college students.

STEP 1: Expand the number of YAL chapters across the country to over 500 nationwide. America’s college campuses are covered with YAL chapters actively recruiting and educating hundreds of thousands of students.

STEP 2: Recruit 10,000 NEW YAL members and collect more than 150,000 student sign-ups. YAL is building a massive network and a strong foundation to reach the next generation for years to come.

STEP 3: Train an ELITE group of top 1,7000 student leaders on how to WIN ON PRINCIPLE. YAL’s top student leaders receive exclusive training on the strategies and tactics to win and advance the ideas of liberty.

STEP 4: Mobilize YAL-trained activists who have knocked on more than 6,000,000 doors to promote liberty causes and candidates. It’s called OPERATION WIN AT THE DOOR, and through it, YAL-trained students have knocked doors to help nearly 400 pro-liberty legislators win crucial races and push for important pro-liberty legislation.

STEP 5: Fight tyrannical campus policies and college administrators through YAL’s Student Rights Campaign. YAL chapters and members have made major policy changes on free speech, self-defence, and defunding woke campus programs, which now impact more than 3,100,000 students every year.

Young Americans for Liberty, 3267 Bee Cave Rd, Ste 107-65, Austin, TX 78746, United States

Source:  editor.thepostmillennial.com

United Nations – Information Service Vienna – 26 June 2025

The global illicit drug trade continues to exact a devastating toll: claiming lives, ravaging public health services, and fuelling violence and organized crime.

Drug trafficking is tearing through communities with substances that are more potent, more dangerous, and more deadly than ever. Meanwhile, criminal networks prey on the most vulnerable – particularly women and youth – as they rake in hundreds of billions annually through the illicit drug trade.

This year, we shine a light on prevention as the most essential strategy for halting the flow of drugs that fuels organized crime worldwide.

We must reduce demand through investing in education, treatment, harm-reduction measures and care; target the machinery of production by eliminating illicit laboratories and offering farmers viable alternatives; and sever trafficking networks by strengthening global trade routes and choking the financial flows of criminal networks, while always ensuring respect for human rights.

Let us recommit to ending drug abuse and trafficking, uniting to dismantle criminal networks, and breaking the cycle of suffering and destruction once and for all.

Source:  https://unis.unvienna.org/unis/pressrels/2025/unissgsm1507.html

By Joe Rossiter – The Mail on Sunday-  29 June 2025 

More than a quarter of police and crime commissioners have written to the policing minister calling for cannabis to be upgraded to a class A substance, The Mail on Sunday can reveal.

In the stark letter to Dame Diana Johnson MP, seen exclusively by this newspaper, 14 police chiefs claim the effect of the drug in society ‘may be far worse’ than heroin.

They warn that ‘we cannot allow this to become the Britain of the future’. And they also hit out at the recent report by the London Commission – backed by Labour London mayor Sir Sadiq Khan – which suggested decriminalising small amounts of cannabis, which is currently a class B drug.

‘Heroin can kill quickly but the cumulative effect of cannabis in our society may be far worse,’ the letter states. 

It adds that class A status – which comes with potential life sentences for suppliers – was the way forward ‘rather than effective decriminalising’.

And renowned psychiatrist Professor Sir Robin Murray, of King’s College London, told The Mail on Sunday that the UK may now be ‘at the beginnings of an epidemic of cannabis-induced psychosis’ which could overwhelm NHS mental health services.

The commissioners also pointed to other countries where laws are laxer, warning that the US has seen ‘unofficial pharmacies’ selling cannabis and the powerful opiate fentanyl alongside one another, while Portugal has been forced to consider reversing drug decriminalisation after a 30-fold increase in psychosis.

They said cannabis’s effects were so devastating it had ‘more birth defects associated with it than thalidomide’ – the notorious morning sickness drug which caused deformities among thousands of babies in the 1950s and 1960s.

More than a quarter of police and crime commissioners have written to the policing minister calling for cannabis to be upgraded to a class A substance (file pic)

Marcus Monzo, 37, was last week found guilty of 14-year-old Daniel Anjorin’s murder while in a state of cannabis-induced psychosis Monzo attacked the teenager with a samurai sword in Hainault, east London, last May

Their warnings came after Marcus Monzo, 37, was last week found guilty of 14-year-old Daniel Anjorin’s murder after he attacked him with a samurai sword in Hainault, east London, while in a state of cannabis-induced psychosis.

David Sidwick, Police and Crime Commissioner for Dorset, said cannabis legislation was ‘clearly not fit for purpose’ and likened it to ‘using a machete for brain surgery’. 

He added the public wanted to see ‘tougher measures’ for cannabis possession because it was a gateway to harder drugs.

His Devon and Cornwall counterpart Alison Hernandez said: ‘The fact that we’ve been so blase about cannabis in society means that people think it’s legal and normal, and it’s not. 

‘We’ve got to show them that it’s not, and the way you do that is to be quite fierce in your enforcement arrangements.’

Latest figures show three in four people caught with cannabis avoid appearing in court, while 87 per cent of children and young people in alcohol and drug treatment cited cannabis dependency, compared to 39 per cent for alcohol.

In the stark letter to Dame Diana Johnson MP, 14 police chiefs claim the effect of the drug in society ‘may be far worse’ than heroin

David Sidwick, Police and Crime Commissioner for Dorset, said he wanted to see ‘tougher measures’ for cannabis possession because it was a gateway to harder drugs (file pic)

Stuart Reece, an Australian clinician and cannabis researcher quoted in the letter said more than 90 per cent of hard drug addicts he encountered had started with cannabis.

He said pro-cannabis campaigners had the view it was ‘my right to use drugs and destroy my body and you will pay for it through the NHS’.

Dr Karen Randall, a physician in the US state of Colorado where recreational cannabis was legalised in 2012, said healthcare costs linked to the drug are ‘exorbitant’.

A Home Office spokesman said: ‘We work with partners across health, policing and wider public services to drive down drug use, ensure more people receive timely treatment and support, and make our streets and communities safer.’

Source: https://www.dailymail.co.uk/news/article-14857305/Cannabis-worse-society-heroin-police-tsars-upgrade-class.html

General News – Saturday 2025-06-28

Vice President Prof Naana Jane Opoku-Agyemang has emphasised the urgent need for increased investment in drug prevention programs, citing clear evidence of the devastating impact of illicit drugs on Ghanaian society.

Speaking at the 2025 World Drug Day event at the Accra International Conference Centre, Vice President Opoku-Agyemang called for action to prevent illicit drug use in the country, as reported by 3news.com on June 27, 2025.

She highlighted the rising prevalence of drug abuse and its detrimental effects on public health, safety, and economic productivity.

The Vice President stressed the importance of a multi-faceted approach to combating the drug problem, which should include education, awareness campaigns, and rehabilitation services.

She noted that while Ghana has made progress against conventional narcotics, the shift to synthetic opioids requires adaptability.

“The evidence is clear: invest in prevention,” she stated, underscoring the theme of World Drug Day 2025.

She added, “We must recognise the urgency of this issue and rise to the occasion to implement appropriate and pragmatic preventive measures.”

Prof Opoku-Agyemang emphasized that prevention is key to mitigating the long-term consequences of drug abuse and building a healthier, more prosperous nation.

She commended the Narcotics Control Commission for its dedication to combating drug abuse and illicit trafficking.

The government is committed to working with stakeholders to implement effective strategies.

She referenced recent operations by the Commission, which resulted in the seizure of large quantities of illicit substances and the dismantling of criminal syndicates, showcasing Ghana’s commitment to the fight against drugs.

The call for increased investment comes amid growing concerns about the accessibility and use of illicit drugs across the country.

The Vice President urged stakeholders to provide the Commission with the necessary tools, training, and resources to stay ahead of evolving threats.

“We must also address substance use disorders with compassion,” she emphasised.

Her remarks signal a renewed focus on this critical issue and the protection of the well-being of Ghanaian citizens.

“The operationalisation of the Substance Use Disorder Rehabilitation Fund is a commendable move, and we must ensure its effective implementation,” she concluded.

Source:  https://www.ghanaweb.com/GhanaHomePage/NewsArchive/The-evidence-is-clear-invest-in-prevention-Vice-President-1989525

Prime Minister Paetongtarn has declared drug prevention a national priority on the International Day Against Drug Abuse and Illicit Trafficking, urging nationwide support for rehabilitation, education, and community action to tackle Thailand’s drug crisis.

On Thursday (June 26), Paetongtarn delivered a speech in line with the United Nations’ declaration. She highlighted that drug abuse and trafficking continue to be persistent global and regional threats, severely affecting lives, public order, and national security.

She reaffirmed Thailand’s commitment to working with government agencies, the private sector, and civil society to combat this challenge.

The Prime Minister announced that drug prevention and resolution have been declared a national priority requiring urgent and tangible action. This initiative will include legal measures and coordinated efforts across central and regional authorities to curb drug smuggling at border areas and dismantle drug trafficking networks decisively.

In response to these threats, the government has launched the Seal, Stop, Safe strategy, which strengthens border control in 52 districts to prevent transborder drug trafficking and transnational crime. Inspections at both permanent and temporary border checkpoints, including natural crossings, have been intensified.

These efforts have led to a rise in the black-market price of methamphetamine, indicating a reduction in drug accessibility, she said.

She called on administrative leaders, provincial governors, community leaders, and particularly families, to collaborate in monitoring and protecting communities.

Paetongtarn also expressed gratitude to all sectors—public, private, and community—for their united efforts in protecting Thai society and future generations. She extended her words of encouragement to those undergoing rehabilitation, wishing them a successful return to a healthy, normal life.

“We invite all Thai people to unite and participate in the prevention and resolution of drug-related issues under the Stop Drugs, Start Power – Unite Thai Strength to End Drug Threats campaign. Let us work together to protect our society and secure a better future for our children,” the Prime Minister concluded.

Source:  https://www.nationthailand.com/news/general/40051801

by Sarjna Rai – New Delhi –  Jun 26 2025 

World Drug Day 2025 theme, “Break the Cycle. #StopOrganizedCrime,” urges global action against drug abuse and illicit trafficking.(Photo: Adobestock)
Every year on 26 June, the world observes the International Day Against Drug Abuse and Illicit Trafficking—also known as “World Drug Day”—to raise awareness of the global drug crisis and promote multilateral action toward prevention, treatment, and rehabilitation.

History & Theme

On December 7, 1987, the General Assembly of the United Nations set aside the 26th day of June of each year as International Day Against Illicit Trafficking of Drugs and other Substances of Abuse to be observed worldwide. 
The theme for 2025, Break the Cycle. #StopOrganisedCrime, emphasises the significance of focused long-term action to disrupt the link between drug trafficking and organised crime, both of which fuel violence, corruption, and instability across regions. 

Source:  https://www.business-standard.com/health/international-day-against-drug-abuse-2025-theme-history-significance-125062600553_1.html

by Sophie Kilusu, TV47 – Kenya – June 27, 2025

The National Authority for the Campaign Against Alcohol and Drug Abuse (NACADA) has emphasized the critical role of prevention in addressing the growing threat of substance abuse in Kenya.

Speaking at a public forum, NACADA Chairperson Stephen Mairori reiterated that preventive efforts are not only economically prudent but also offer the most sustainable way to protect the country’s future generations.“Prevention is not only cost-effective but also one of the most sustainable strategies in this fight,” Mairori stated.

Mairori has also emphasized that proactive measures such as educating the youth, empowering families, and fostering supportive environments are essential in stopping addiction before it begins. “Every shilling spent on prevention saves countless lives and resources that would otherwise go into treatment and rehabilitation,” he added.

The chairperson pointed out that NACADA’s initiatives are aligned with the government’s Bottom-Up Economic Transformation Agenda (BETA), which focuses on inclusive growth and sustainable development.

According to Mairori, curbing drug and substance abuse is a crucial step in building healthier and more productive communities.“When we prevent drug abuse, we secure our future workforce, reduce crime, and promote national development,” he said.

Mairori’s remarks come at a time when Kenya is grappling with rising cases of drug and substance abuse, especially among the youth.

In response, NACADA has intensified its community outreach programs, school awareness campaigns, and partnerships with various stakeholders to foster a national culture of prevention.

Additionally, he has called on parents, schools, faith-based institutions, and local leaders to join hands in creating an environment where young people can thrive without falling prey to drugs.

With the nation’s future hanging in the balance, NACADA continues to champion the message that prevention is not just a strategy, it is a necessity.

Source:  https://www.tv47.digital/prevention-is-key-to-winning-the-war-on-drug-abuse-107008/

Key Takeaways
NACo submitted recommendations to the White House Office of National Drug Control Policy to ensure the 2026 National Drug Control Strategy reflects the needs and realities of county governments.
Counties are essential intergovernmental partners in addressing illicit substance use through prevention, treatment, recovery and public safety efforts at the local level.

On June 20, NACo submitted formal comments to the White House Office of National Drug Control Policy (ONDCP) to help shape the development of its 2026 National Drug Control Strategy. This strategy serves as the nation’s blueprint for reducing illicit drug use, and the ONDCP plays a central role in coordinating federal drug policy across government agencies. As counties remain on the frontlines of the opioid and broader substance use epidemic, ONDCP invited NACo to share the county government perspectives on federal priorities and polices that support prevention, treatment, recovery and public safety across the country.

Counties invest $107 billion annually in justice and public safety and $163 billion in community health systems, funding and administering services that are directly involved in responding to the substance use crisis. NACo’s comments emphasized the vital role counties play and the importance of federal partnership in delivering life-saving services and building long-term recovery systems.

Key recommendation for the 2026 National Drug Control Strategy

  • Invest in the peer workforce: NACo urged federal investment in peer support through training, certification programs and reimbursement pathways for peer-delivered services. Peer specialists play a critical role in county crisis response teams, treatment navigation and long-term recovery efforts.
  • Expand community-based recovery ecosystems: NACo urged expanded federal investment in community-based services such as crisis care, prevention programs, housing, employment supports and peer-run services. These investments are essential to building accessible, regional systems of care that meet rising behavioral health needs.
  • Promote awareness and reduce stigma: NACo urged support for locally led communication strategies that increase awareness, engage underserved populations and reduce stigma around substance use. County officials often serve as trusted messengers and are well-positioned to promote prevention and recovery through tailored outreach.
  • Remove barriers to services, housing and employment: NACo urged the federal government to remove structural barriers that limit access to care—such as the Medicaid Inmate Exclusion Policy and the Institutions for Mental Diseases (IMD) Exclusion—and to integrate housing and employment supports into recovery frameworks for those with SUDS or who are in recovery. These changes are necessary to foster long-term reintegration and community participation.
  • Continuation of existing federal programs: NACo urged continued investment in critical programs like the Drug-Free Communities (DFC) program and the High Intensity Drug Trafficking Areas (HIDTA) program. These initiatives are foundational to local prevention and enforcement efforts, and proposed cuts in the President’s FY 2026 budget could undermine their effectiveness and coordination under ONDCP.

Impact on counties

Counties are not only implementers of public health and safety strategies, but they are also key innovators and partners in national efforts to address substance use. As stewards of opioid settlement dollars and administrators of behavioral health and justice systems, counties are investing in sustainable, evidence-based solutions. But these efforts depend on strong federal support, including robust funding for ONDCP-aligned programs and active engagement in local implementation challenges.

NACo will continue to advocate for county priorities and collaborate with ONDCP to ensure the 2026 strategy and other federal drug policies and priorities reflect the realities and needs of communities across the country.

Source:  https://www.naco.org/news/naco-submits-recommendations-2026-national-drug-control-strategy

Back to top of page

Powered by WordPress